| 1 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035046)
|
| 2 |
ClinicalTrials.gov (NCT02442687) JKB-121 for the Treatment of Nonalcoholic Steatohepatitis. U.S. National Institutes of Health.
|
| 3 |
The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
|
| 4 |
An unbiased approach de-livers unexpected insight into torsin biology.J Clin Invest. 2019 Nov 1;129(11):4576-4579. doi: 10.1172/JCI132442.
|
| 5 |
The Influence of Trehalose on Atherosclerosis and Hepatic Steatosis in Apolipoprotein E Knockout Mice.Int J Mol Sci. 2019 Mar 28;20(7):1552. doi: 10.3390/ijms20071552.
|
| 6 |
Role of ghrelin isoforms in the mitigation of hepatic inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress after bariatric surgery in rats.Int J Obes (Lond). 2020 Feb;44(2):475-487. doi: 10.1038/s41366-019-0420-2. Epub 2019 Jul 19.
|
| 7 |
Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation.Food Funct. 2018 Feb 21;9(2):906-916. doi: 10.1039/c7fo01051f.
|
| 8 |
Eugenol Reduces LDL Cholesterol and Hepatic Steatosis in Hypercholesterolemic Rats by Modulating TRPV1 Receptor.Sci Rep. 2019 Sep 30;9(1):14003. doi: 10.1038/s41598-019-50352-4.
|
| 9 |
In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infection.HIV Med. 2018 Oct;19(9):597-604. doi: 10.1111/hiv.12638. Epub 2018 Jun 22.
|
| 10 |
CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.Int Immunopharmacol. 2019 Jul;72:224-234. doi: 10.1016/j.intimp.2019.04.021. Epub 2019 Apr 16.
|
| 11 |
Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study.Oncologist. 2019 Aug;24(8):e653-e661. doi: 10.1634/theoncologist.2018-0370. Epub 2019 Jan 24.
|
| 12 |
Increased plasma levels of the lipoperoxyl radical-derived vitamin E metabolite -tocopheryl quinone are an early indicator of lipotoxicity in fatty liver subjects.Free Radic Biol Med. 2019 Feb 1;131:115-125. doi: 10.1016/j.freeradbiomed.2018.11.036. Epub 2018 Nov 30.
|
| 13 |
Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis.Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3181-3185. doi: 10.1073/pnas.1700172114. Epub 2017 Mar 7.
|
| 14 |
Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.Mol Metab. 2017 Oct;6(10):1304-1312. doi: 10.1016/j.molmet.2017.07.007. Epub 2017 Jul 18.
|
| 15 |
Omega-3 polyunsaturated fatty acids protect human hepatoma cells from developing steatosis through FFA4 (GPR120).Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Feb;1863(2):105-116. doi: 10.1016/j.bbalip.2017.11.002. Epub 2017 Nov 7.
|
| 16 |
Selective Inhibition of FOXO1 Activator/Repressor Balance Modulates Hepatic Glucose Handling.Cell. 2017 Nov 2;171(4):824-835.e18. doi: 10.1016/j.cell.2017.09.045. Epub 2017 Oct 19.
|
| 17 |
Interferon regulatory factor 3 constrains IKK/NF-B signaling to alleviate hepatic steatosis and insulin resistance.Hepatology. 2014 Mar;59(3):870-85. doi: 10.1002/hep.26751. Epub 2014 Jan 30.
|
| 18 |
The antipsychotics sulpiride induces fatty liver in rats via phosphorylation of insulin receptor substrate-1 at Serine 307-mediated adipose tissue insulin resistance.Toxicol Appl Pharmacol. 2018 Apr 15;345:66-74. doi: 10.1016/j.taap.2018.02.023. Epub 2018 Mar 15.
|
| 19 |
Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers.Int J Obes (Lond). 2018 Sep;42(9):1544-1555. doi: 10.1038/s41366-018-0062-9. Epub 2018 May 1.
|
| 20 |
High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism.Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):3138-3143. doi: 10.1073/pnas.1713837115. Epub 2018 Mar 5.
|
| 21 |
Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing de novo PCSK9 expression in mice.J Biol Chem. 2019 Jun 7;294(23):9037-9047. doi: 10.1074/jbc.RA119.008094. Epub 2019 Apr 19.
|
| 22 |
Low-density lipoprotein receptor-related protein-1 dysfunction synergizes with dietary cholesterol to accelerate steatohepatitis progression.J Biol Chem. 2018 Jun 22;293(25):9674-9684. doi: 10.1074/jbc.RA118.001952. Epub 2018 May 11.
|
| 23 |
Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH.Sci Rep. 2018 Feb 5;8(1):2362. doi: 10.1038/s41598-018-19658-7.
|
| 24 |
NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice.PLoS One. 2019 Feb 22;14(2):e0212523. doi: 10.1371/journal.pone.0212523. eCollection 2019.
|
| 25 |
Purinergic P2X7 receptor blockade mitigates alcohol-induced steatohepatitis and intestinal injury by regulating MEK1/2-ERK1/2 signaling and egr-1 activity.Int Immunopharmacol. 2019 Jan;66:52-61. doi: 10.1016/j.intimp.2018.11.012. Epub 2018 Nov 13.
|
| 26 |
Regulation of mitochondrial trifunctional protein modulates nonalcoholic fatty liver disease in mice.J Lipid Res. 2018 Jun;59(6):967-973. doi: 10.1194/jlr.M080952. Epub 2018 Mar 26.
|
| 27 |
Acid sphingomyelinase deficiency in Western diet-fed mice protects against adipocyte hypertrophy and diet-induced liver steatosis.Mol Metab. 2017 Mar 12;6(5):416-427. doi: 10.1016/j.molmet.2017.03.002. eCollection 2017 May.
|
| 28 |
Serotonin signals through a gut-liver axis to regulate hepatic steatosis.Nat Commun. 2018 Nov 16;9(1):4824. doi: 10.1038/s41467-018-07287-7.
|
| 29 |
Targeted inactivation of copper transporter Atp7b in hepatocytes causes liver steatosis and obesity in mice.Am J Physiol Gastrointest Liver Physiol. 2017 Jul 1;313(1):G39-G49. doi: 10.1152/ajpgi.00312.2016. Epub 2017 Apr 20.
|
| 30 |
Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis?.Ann Hepatol. 2019 Jan-Feb;18(1):78-88. doi: 10.5604/01.3001.0012.7865.
|
| 31 |
UBE3A Suppresses Overnutrition-Induced Expression of the Steatosis Target Genes of MLL4 by Degrading MLL4.Hepatology. 2019 Mar;69(3):1122-1134. doi: 10.1002/hep.30284. Epub 2019 Feb 7.
|
| 32 |
Thioredoxin-1 promotes macrophage reverse cholesterol transport and protects liver from steatosis.Biochem Biophys Res Commun. 2019 Sep 3;516(4):1103-1109. doi: 10.1016/j.bbrc.2019.06.109. Epub 2019 Jul 4.
|
| 33 |
Liver Transplantation for Progressive Familial Intrahepatic Cholestasis.Ann Transplant. 2018 Sep 25;23:666-673. doi: 10.12659/AOT.909941.
|
| 34 |
News on the molecular regulation and function of hepatic low-density lipoprotein receptor and LDLR-related protein 1.Curr Opin Lipidol. 2017 Jun;28(3):241-247. doi: 10.1097/MOL.0000000000000411.
|
| 35 |
Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease.Diabetes Metab Res Rev. 2019 May;35(4):e3123. doi: 10.1002/dmrr.3123. Epub 2019 Jan 10.
|
| 36 |
An allosteric mechanism for potent inhibition of human ATP-citrate lyase.Nature. 2019 Apr;568(7753):566-570. doi: 10.1038/s41586-019-1094-6. Epub 2019 Apr 3.
|
| 37 |
A soluble activin receptor type IIb prevents the effects of androgen deprivation on body composition and bone health.Endocrinology. 2010 Sep;151(9):4289-300. doi: 10.1210/en.2010-0134. Epub 2010 Jun 23.
|
| 38 |
ADAMTS13 deficiency promotes microthrombosis in a murine model of diet-induced liver steatosis.Thromb Haemost. 2017 Jan 5;117(1):19-26. doi: 10.1160/TH16-03-0195. Epub 2016 Sep 8.
|
| 39 |
Aldehyde dehydrogenase 2 and beta3-adrenergic receptor gene polymorphisms: their association with elevated liver enzymes and metabolic syndrome.Metabolism. 2003 Sep;52(9):1096-101. doi: 10.1016/s0026-0495(03)00183-5.
|
| 40 |
Unusual first presentation of a metabolic disorder.BMJ Case Rep. 2019 Mar 22;12(3):e226716. doi: 10.1136/bcr-2018-226716.
|
| 41 |
TNFalpha-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish S-adenosylhomocysteine hydrolase.Development. 2009 Mar;136(5):865-75. doi: 10.1242/dev.027565.
|
| 42 |
Melatonin improves insulin resistance and hepatic steatosis through attenuation of alpha-2-HS-glycoprotein.J Pineal Res. 2018 Sep;65(2):e12493. doi: 10.1111/jpi.12493. Epub 2018 Apr 21.
|
| 43 |
Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats. J Biol Chem. 2019 Mar 15;294(11):4272-4281. doi: 10.1074/jbc.RA118.006158. Epub 2019 Jan 16.
|
| 44 |
Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):525-534. doi: 10.1016/j.bbadis.2018.12.014. Epub 2018 Dec 15.
|
| 45 |
Slow-metabolizing ADH1B and inactive heterozygous ALDH2 increase vulnerability to fatty liver in Japanese men with alcohol dependence.J Gastroenterol. 2018 May;53(5):660-669. doi: 10.1007/s00535-017-1402-6. Epub 2017 Oct 23.
|
| 46 |
Serum Angiopoietin-like peptide 4 levels in patients with hepatic steatosis.Cytokine. 2018 Nov;111:496-499. doi: 10.1016/j.cyto.2018.05.030. Epub 2018 Jun 14.
|
| 47 |
Alleviation of fatty liver in a rat model by enhancing N(1)-methylnicotinamide bioavailability through aldehyde oxidase inhibition.Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):203-210. doi: 10.1016/j.bbrc.2018.11.008. Epub 2018 Nov 13.
|
| 48 |
Hepatic and cardiac beneficial effects of a long-acting Fc-apelin fusion protein in diet-induced obese mice.Diabetes Metab Res Rev. 2018 Jul;34(5):e2997. doi: 10.1002/dmrr.2997. Epub 2018 Mar 25.
|
| 49 |
Apolipoprotein A-I improves hepatic autophagy through the AMPK pathway.Biochimie. 2019 Oct;165:210-218. doi: 10.1016/j.biochi.2019.08.001. Epub 2019 Aug 8.
|
| 50 |
Human leucine zipper protein promotes hepatic steatosis via induction of apolipoprotein A-IV.FASEB J. 2017 Jun;31(6):2548-2561. doi: 10.1096/fj.201601227R. Epub 2017 Feb 28.
|
| 51 |
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: Acomparison between familial hypobetalipoproteinemia and familial combined hypolipidemia.J Clin Lipidol. 2017 Sep-Oct;11(5):1234-1242. doi: 10.1016/j.jacl.2017.06.013. Epub 2017 Jun 24.
|
| 52 |
Long non-coding RNA NEAT1 promotes steatosis via enhancement of estrogen receptor alpha-mediated AQP7 expression in HepG2 cells.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1782-1787. doi: 10.1080/21691401.2019.1604536.
|
| 53 |
Effects of Qutanhuoxue Decoction on AQP7 and AQP9 Expression in Nonalcoholic Fatty Liver Model Rats.Evid Based Complement Alternat Med. 2019 Jun 2;2019:5709626. doi: 10.1155/2019/5709626. eCollection 2019.
|
| 54 |
The influence of AICAR - direct activator of AMP-activated protein kinase (AMPK) - on liver proteome in apoE-knockout mice.Eur J Pharm Sci. 2017 Jun 15;104:406-416. doi: 10.1016/j.ejps.2017.04.021. Epub 2017 Apr 26.
|
| 55 |
Dynamic repression by BCL6 controls the genome-wide liver response to fasting and steatosis.Elife. 2019 Apr 15;8:e43922. doi: 10.7554/eLife.43922.
|
| 56 |
Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease.Atherosclerosis. 2011 Oct;218(2):378-85. doi: 10.1016/j.atherosclerosis.2011.05.014. Epub 2011 May 18.
|
| 57 |
Biliverdin reductase and bilirubin in hepatic disease.Am J Physiol Gastrointest Liver Physiol. 2018 Jun 1;314(6):G668-G676. doi: 10.1152/ajpgi.00026.2018. Epub 2018 Mar 1.
|
| 58 |
Effect of oleic acid on induction of steatosis and cytotoxicity in BRL 3A cells.J Cell Biochem. 2019 Dec;120(12):19541-19554. doi: 10.1002/jcb.29262. Epub 2019 Jul 1.
|
| 59 |
Bone marrow-derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells.J Pathol. 2019 Aug;248(4):488-500. doi: 10.1002/path.5275. Epub 2019 May 7.
|
| 60 |
Carbonic anhydrase III (Car3) is not required for fatty acid synthesis and does not protect against high-fat diet induced obesity in mice.PLoS One. 2017 Apr 24;12(4):e0176502. doi: 10.1371/journal.pone.0176502. eCollection 2017.
|
| 61 |
Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice.Cell Mol Immunol. 2019 Nov;16(11):878-886. doi: 10.1038/s41423-018-0032-0. Epub 2018 May 7.
|
| 62 |
ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P.Cell. 2018 Sep 20;175(1):133-145.e15. doi: 10.1016/j.cell.2018.08.020. Epub 2018 Sep 13.
|
| 63 |
Caveolin1 protects against diet induced hepatic lipid accumulation in mice.PLoS One. 2017 Jun 1;12(6):e0178748. doi: 10.1371/journal.pone.0178748. eCollection 2017.
|
| 64 |
Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways.J Clin Invest. 2001 May;107(10):1263-73. doi: 10.1172/JCI11596.
|
| 65 |
Chemokine (C-C motif) ligand 2 gene ablation protects low-density lipoprotein and paraoxonase-1 double deficient mice from liver injury, oxidative stress and inflammation.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1555-1566. doi: 10.1016/j.bbadis.2019.03.006. Epub 2019 Mar 21.
|
| 66 |
Inflammation and Ectopic Fat Deposition in the Aging Murine Liver Is Influenced by CCR2.Am J Pathol. 2020 Feb;190(2):372-387. doi: 10.1016/j.ajpath.2019.10.016. Epub 2019 Dec 13.
|
| 67 |
CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis.J Hepatol. 2014 Dec;61(6):1365-75. doi: 10.1016/j.jhep.2014.07.006. Epub 2014 Jul 15.
|
| 68 |
Genetic variation in human carboxylesterase CES1 confers resistance to hepatic steatosis.Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Jul;1863(7):688-699. doi: 10.1016/j.bbalip.2018.04.002. Epub 2018 Apr 7.
|
| 69 |
Cadmium exposure exacerbates severe hyperlipidemia and fatty liver changes in zebrafish via impairment of high-density lipoproteins functionality.Toxicol In Vitro. 2018 Mar;47:249-258. doi: 10.1016/j.tiv.2017.11.007. Epub 2017 Nov 29.
|
| 70 |
High-fat diet-induced plasma protein and liver changes in obese rats can be attenuated by melatonin supplementation.Nutr Res. 2017 Jun;42:51-63. doi: 10.1016/j.nutres.2017.04.011. Epub 2017 May 5.
|
| 71 |
Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C.BMC Gastroenterol. 2014 Jul 27;14:131. doi: 10.1186/1471-230X-14-131.
|
| 72 |
Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents.Liver Int. 2018 Dec;38(12):2301-2308. doi: 10.1111/liv.13955. Epub 2018 Sep 25.
|
| 73 |
Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease.Gut. 2006 Sep;55(9):1313-20. doi: 10.1136/gut.2005.075697. Epub 2006 Jul 6.
|
| 74 |
The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart Study.Atherosclerosis. 2013 May;228(1):175-80. doi: 10.1016/j.atherosclerosis.2013.01.038. Epub 2013 Feb 18.
|
| 75 |
PI3K inhibition protects mice from NAFLD by down-regulating CMKLR1 and NLRP3 in Kupffer cells.J Physiol Biochem. 2017 Nov;73(4):583-594. doi: 10.1007/s13105-017-0589-6. Epub 2017 Sep 13.
|
| 76 |
Ciliary neurotrophic factor analogue aggravates CCl(4)-induced acute hepatic injury in rats.Can J Physiol Pharmacol. 2017 May;95(5):620-623. doi: 10.1139/cjpp-2016-0564. Epub 2016 Dec 8.
|
| 77 |
Urea cycle dysregulation in non-alcoholic fatty liver disease.J Hepatol. 2018 Oct;69(4):905-915. doi: 10.1016/j.jhep.2018.06.023. Epub 2018 Jul 5.
|
| 78 |
Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury.Sci Rep. 2017 Sep 21;7(1):12064. doi: 10.1038/s41598-017-10924-8.
|
| 79 |
Liver steatosis in adult patients on home parenteral nutrition.Eur J Clin Nutr. 2020 Feb;74(2):255-260. doi: 10.1038/s41430-019-0455-4. Epub 2019 Jun 24.
|
| 80 |
The transcription cofactor CRTC1 protects from aberrant hepatic lipid accumulation.Sci Rep. 2016 Nov 21;6:37280. doi: 10.1038/srep37280.
|
| 81 |
Molecular mechanisms related to the hepatoprotective effects of antioxidant-rich extra virgin olive oil supplementation in rats subjected to short-term iron administration.Free Radic Biol Med. 2018 Oct;126:313-321. doi: 10.1016/j.freeradbiomed.2018.08.030. Epub 2018 Aug 25.
|
| 82 |
Diagnostic approaches for diabetic cardiomyopathy.Cardiovasc Diabetol. 2017 Feb 23;16(1):28. doi: 10.1186/s12933-017-0506-x.
|
| 83 |
SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy.J Hepatol. 2018 Jul;69(1):129-141. doi: 10.1016/j.jhep.2018.01.038. Epub 2018 Feb 13.
|
| 84 |
Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in SpragueDawley Rats (?.Biomolecules. 2019 May 4;9(5):171. doi: 10.3390/biom9050171.
|
| 85 |
Cyp1b1 affects external control of mouse hepatocytes, fatty acid homeostasis and signaling involving HNF4 and PPAR.Arch Biochem Biophys. 2016 May 1;597:30-47. doi: 10.1016/j.abb.2016.03.030. Epub 2016 Mar 29.
|
| 86 |
Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development.Integr Biol (Camb). 2017 Aug 14;9(8):662-677. doi: 10.1039/c7ib00027h.
|
| 87 |
Transcriptional Repression of CYP3A4 by Increased miR-200a-3p and miR-150-5p Promotes Steatosis in vitro.Front Genet. 2019 May 28;10:484. doi: 10.3389/fgene.2019.00484. eCollection 2019.
|
| 88 |
Leptin activates hepatic 5'-AMP-activated protein kinase through sympathetic nervous system and 1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin.J Biol Chem. 2012 Nov 23;287(48):40441-7. doi: 10.1074/jbc.M112.384545. Epub 2012 Sep 28.
|
| 89 |
DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoho... Hepatology. 2018 Aug;68(2):496-514.
|
| 90 |
Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice.Hepatology. 2019 Dec;70(6):1972-1985. doi: 10.1002/hep.30765. Epub 2019 Jun 26.
|
| 91 |
Trivalent Chromium Supplementation Ameliorates Oleic Acid-Induced Hepatic Steatosis in Mice.Biol Trace Elem Res. 2019 Jan;187(1):192-201. doi: 10.1007/s12011-018-1368-0. Epub 2018 May 24.
|
| 92 |
Combination of APD668, a G protein-coupled receptor 119 agonist with linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in a murine model of non-alcoholic steatohepatitis with diabetes.Med Mol Morphol. 2019 Mar;52(1):36-43. doi: 10.1007/s00795-018-0200-4. Epub 2018 Jun 29.
|
| 93 |
Purple corn extract induces long-lasting reprogramming and M2 phenotypic switch of adipose tissue macrophages in obese mice.J Transl Med. 2019 Jul 23;17(1):237. doi: 10.1186/s12967-019-1972-6.
|
| 94 |
Treating nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a review of efficacy and safety.Ther Adv Endocrinol Metab. 2018 Jan;9(1):15-28. doi: 10.1177/2042018817741852. Epub 2017 Dec 7.
|
| 95 |
GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3257-3267. doi: 10.1016/j.bbadis.2018.07.012. Epub 2018 Jul 11.
|
| 96 |
Roles of Autophagy and Protein Kinase C-epsilon in Lipid Metabolism of Nonalcoholic Fatty Liver Cell Models.Arch Med Res. 2018 Aug;49(6):381-390. doi: 10.1016/j.arcmed.2018.11.006. Epub 2018 Dec 17.
|
| 97 |
Coupling of COPII vesicle trafficking to nutrient availability by the IRE1-XBP1s axis.Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11776-11785. doi: 10.1073/pnas.1814480116. Epub 2019 May 23.
|
| 98 |
Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice.Am J Pathol. 2010 Jan;176(1):177-86. doi: 10.2353/ajpath.2010.090672. Epub 2009 Dec 11.
|
| 99 |
Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.Am J Pathol. 2012 Oct;181(4):1287-95. doi: 10.1016/j.ajpath.2012.06.011. Epub 2012 Jul 26.
|
| 100 |
Up-regulation of hepatic fatty acid transporters and inhibition/down-regulation of hepatic OCTN2 contribute to olanzapine-induced liver steatosis. Toxicol Lett. 2019 Nov;316:183-193. doi: 10.1016/j.toxlet.2019.08.013. Epub 2019 Aug 19.
|
| 101 |
Botanical oils enriched in n-6 and n-3 FADS2 products are equally effective in preventing atherosclerosis and fatty liver.J Lipid Res. 2015 Jun;56(6):1191-205. doi: 10.1194/jlr.M059170. Epub 2015 Apr 28.
|
| 102 |
Dietary Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Operate by Different Mechanisms to Modulate Hepatic Steatosis and Hyperinsulemia in fa/fa Zucker Rats.Nutrients. 2019 Apr 24;11(4):917. doi: 10.3390/nu11040917.
|
| 103 |
Butyrate Regulates Liver Mitochondrial Function, Efficiency, and Dynamics in Insulin-Resistant Obese Mice.Diabetes. 2017 May;66(5):1405-1418. doi: 10.2337/db16-0924. Epub 2017 Feb 21.
|
| 104 |
Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis C.Liver Int. 2014 Mar;34(3):388-95. doi: 10.1111/liv.12269. Epub 2013 Jul 21.
|
| 105 |
Sodium Butyrate Improves Liver Glycogen Metabolism in Type 2 Diabetes Mellitus.J Agric Food Chem. 2019 Jul 10;67(27):7694-7705. doi: 10.1021/acs.jafc.9b02083. Epub 2019 Jun 28.
|
| 106 |
Fibroblast growth factors in control of lipid metabolism: from biological function to clinical application.Curr Opin Lipidol. 2019 Jun;30(3):235-243. doi: 10.1097/MOL.0000000000000599.
|
| 107 |
The relationship between serum FGF-23 concentration and insulin resistance, prediabetes and dyslipidemia in obese children and adolescents.J Pediatr Endocrinol Metab. 2019 Jul 26;32(7):707-714. doi: 10.1515/jpem-2018-0507.
|
| 108 |
Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitis.Toxicol Appl Pharmacol. 2019 Apr 1;368:49-54. doi: 10.1016/j.taap.2019.02.009. Epub 2019 Feb 19.
|
| 109 |
Transcriptional Regulation of Early Growth Response Gene-1 (EGR1) is Associated with Progression of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients with Insulin Resistance.Med Sci Monit. 2019 Apr 23;25:2293-3004. doi: 10.12659/MSM.914044.
|
| 110 |
Dietary Bile Acids Enhance Growth, and Alleviate Hepatic Fibrosis Induced by a High Starch Diet via AKT/FOXO1 and cAMP/AMPK/SREBP1 Pathway in Micropterus salmoides.Front Physiol. 2019 Nov 19;10:1430. doi: 10.3389/fphys.2019.01430. eCollection 2019.
|
| 111 |
Impact of patatin-like phospholipase domain-containing 3 gene polymorphism (rs738409) on severity of liver disease in HIV/hepatitis C virus-coinfected patients.AIDS. 2016 Jan 28;30(3):465-70. doi: 10.1097/QAD.0000000000000908.
|
| 112 |
Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.J Clin Endocrinol Metab. 2020 Mar 1;105(3):e390-400. doi: 10.1210/clinem/dgz172.
|
| 113 |
Rhesus monkey model of liver disease reflecting clinical disease progression and hepatic gene expression analysis.Sci Rep. 2015 Oct 7;5:15019. doi: 10.1038/srep15019.
|
| 114 |
Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats.PLoS One. 2019 Jun 24;14(6):e0210930. doi: 10.1371/journal.pone.0210930. eCollection 2019.
|
| 115 |
Glucagon-Receptor Signaling Reverses Hepatic Steatosis Independent of Leptin Receptor Expression.Endocrinology. 2020 Jan 1;161(1):bqz013. doi: 10.1210/endocr/bqz013.
|
| 116 |
A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice.Hepatology. 2017 Mar;65(3):950-968. doi: 10.1002/hep.28962. Epub 2017 Jan 30.
|
| 117 |
Glutathione deficiency-elicited reprogramming of hepatic metabolism protects against alcohol-induced steatosis.Free Radic Biol Med. 2019 Nov 1;143:127-139. doi: 10.1016/j.freeradbiomed.2019.07.025. Epub 2019 Jul 24.
|
| 118 |
The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.J Ethnopharmacol. 2017 Jan 4;195:204-213. doi: 10.1016/j.jep.2016.11.020. Epub 2016 Nov 11.
|
| 119 |
Metabolic effects of reduced growth hormone action in fatty liver disease.Hepatol Int. 2018 Sep;12(5):474-481. doi: 10.1007/s12072-018-9893-7. Epub 2018 Sep 11.
|
| 120 |
Inhibition of Ghrelin Activity by Receptor Antagonist [d-Lys-3] GHRP-6 Attenuates Alcohol-Induced Hepatic Steatosis by Regulating Hepatic Lipid Metabolism.Biomolecules. 2019 Sep 21;9(10):517. doi: 10.3390/biom9100517.
|
| 121 |
Wheat-derived arabinoxylan oligosaccharides with bifidogenic properties abolishes metabolic disorders induced by western diet in mice.Nutr Diabetes. 2018 Mar 7;8(1):15. doi: 10.1038/s41387-018-0019-z.
|
| 122 |
Inhibition of Gastric Inhibitory Polypeptide Receptor Signaling in Adipose Tissue Reduces Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice.Diabetes. 2017 Apr;66(4):868-879. doi: 10.2337/db16-0758. Epub 2017 Jan 17.
|
| 123 |
GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice.Endocrinology. 2018 Sep 1;159(9):3340-3350. doi: 10.1210/en.2018-00416.
|
| 124 |
Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1. Antioxid Redox Signal. 2017 Aug 20;27(6):313-327.
|
| 125 |
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis.FASEB J. 2019 Feb;33(2):2809-2822. doi: 10.1096/fj.201801373RR. Epub 2018 Oct 10.
|
| 126 |
Protective effect of lodoxamide on hepatic steatosis through GPR35.Cell Signal. 2019 Jan;53:190-200. doi: 10.1016/j.cellsig.2018.10.001. Epub 2018 Oct 7.
|
| 127 |
Mitochondrial adaptations to obesity-related oxidant stress.Arch Biochem Biophys. 2000 Jun 15;378(2):259-68. doi: 10.1006/abbi.2000.1829.
|
| 128 |
An HDAC3-PROX1 corepressor module acts on HNF4 to control hepatic triglycerides.Nat Commun. 2017 Sep 15;8(1):549. doi: 10.1038/s41467-017-00772-5.
|
| 129 |
HDAC5 integrates ER stress and fasting signals to regulate hepatic fatty acid oxidation.J Lipid Res. 2018 Feb;59(2):330-338. doi: 10.1194/jlr.M080382. Epub 2017 Dec 11.
|
| 130 |
Hepatocyte nuclear factor 1 suppresses steatosis-associated liver cancer by inhibiting PPAR transcription.J Clin Invest. 2017 May 1;127(5):1873-1888. doi: 10.1172/JCI90327. Epub 2017 Apr 10.
|
| 131 |
Loss of hnRNP A1 in murine skeletal muscle exacerbates high-fat diet-induced onset of insulin resistance and hepatic steatosis.J Mol Cell Biol. 2020 May 18;12(4):277-290. doi: 10.1093/jmcb/mjz050.
|
| 132 |
HDL flux is higher in patients with nonalcoholic fatty liver disease.Am J Physiol Endocrinol Metab. 2019 Nov 1;317(5):E852-E862. doi: 10.1152/ajpendo.00193.2019. Epub 2019 Sep 10.
|
| 133 |
Serotonin induced hepatic steatosis is associated with modulation of autophagy and notch signaling pathway.Cell Commun Signal. 2018 Nov 8;16(1):78. doi: 10.1186/s12964-018-0282-6.
|
| 134 |
T Cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune Programming.Hepatology. 2020 Feb;71(2):477-494. doi: 10.1002/hep.30952. Epub 2019 Dec 31.
|
| 135 |
Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.PLoS One. 2015 May 11;10(5):e0125962. doi: 10.1371/journal.pone.0125962. eCollection 2015.
|
| 136 |
Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.Gastroenterology. 2019 Sep;157(3):777-792.e14. doi: 10.1053/j.gastro.2019.05.002. Epub 2019 May 9.
|
| 137 |
Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model.J Immunol. 2008 Oct 1;181(7):4656-65. doi: 10.4049/jimmunol.181.7.4656.
|
| 138 |
Abnormal zinc and copper metabolism in hepatic steatosis.Boll Chim Farm. 1996 Nov;135(10):591-7.
|
| 139 |
PTEN influences insulin and lipid metabolism in bovine hepatocytes in vitro.J Dairy Res. 2019 Feb;86(1):73-76. doi: 10.1017/S0022029919000128. Epub 2019 Mar 1.
|
| 140 |
Integrin 1-null mice exhibit improved fatty liver when fed a high fat diet despite severe hepatic insulin resistance.J Biol Chem. 2015 Mar 6;290(10):6546-57. doi: 10.1074/jbc.M114.615716. Epub 2015 Jan 15.
|
| 141 |
Nonalcoholic fatty liver disease impairs expression of the type II inositol 1,4,5-trisphosphate receptor.Hepatology. 2018 Feb;67(2):560-574. doi: 10.1002/hep.29588. Epub 2018 Jan 2.
|
| 142 |
Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux.Sci Rep. 2018 Mar 7;8(1):4108. doi: 10.1038/s41598-018-22339-0.
|
| 143 |
Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor -Klotho.Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16137-42. doi: 10.1073/pnas.1205951109. Epub 2012 Sep 17.
|
| 144 |
Dietary -lactalbumin induced fatty liver by enhancing nuclear liver X receptor /sterol regulatory element-binding protein-1c/PPAR expression and minimising PPAR/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.Br J Nutr. 2017 Dec;118(11):914-929. doi: 10.1017/S000711451700232X. Epub 2017 Nov 27.
|
| 145 |
Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.Free Radic Biol Med. 2018 Oct;126:269-286. doi: 10.1016/j.freeradbiomed.2018.08.024. Epub 2018 Aug 22.
|
| 146 |
Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 simultaneously alleviate high-fat diet-induced colitis, endotoxemia, liver steatosis, and obesity in mice.Nutr Res. 2019 Jul;67:78-89. doi: 10.1016/j.nutres.2019.03.008. Epub 2019 Mar 20.
|
| 147 |
An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity.Rev Esp Enferm Dig. 2019 Apr;111(4):294-300. doi: 10.17235/reed.2019.5942/2018.
|
| 148 |
Perilipin 5 and Lipocalin 2 Expression in Hepatocellular Carcinoma.Cancers (Basel). 2019 Mar 19;11(3):385. doi: 10.3390/cancers11030385.
|
| 149 |
A case of generalized lipodystrophy-associated progeroid syndrome treated by leptin replacement with short and long-term monitoring of the metabolic and endocrine profiles.Endocr J. 2020 Feb 28;67(2):211-218. doi: 10.1507/endocrj.EJ19-0226. Epub 2019 Nov 8.
|
| 150 |
Update on the synergistic effect of HSL and insulin in the treatment of metabolic disorders.Ther Adv Endocrinol Metab. 2019 Sep 20;10:2042018819877300. doi: 10.1177/2042018819877300. eCollection 2019.
|
| 151 |
Effect of Non-alcoholic Fatty Liver Disease on Transaminase Levels and Transient Elastography in Patients with Chronic Hepatitis B.Cureus. 2019 Oct 25;11(10):e5995. doi: 10.7759/cureus.5995.
|
| 152 |
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model.Cell Physiol Biochem. 2018;47(6):2233-2249. doi: 10.1159/000491535. Epub 2018 Jul 5.
|
| 153 |
(7)-Integrin and MAdCAM-1 play opposing roles during the development of non-alcoholic steatohepatitis.J Hepatol. 2017 Jun;66(6):1251-1264. doi: 10.1016/j.jhep.2017.02.001. Epub 2017 Feb 10.
|
| 154 |
Liver ASK1 protects from non-alcoholic fatty liver disease and fibrosis.EMBO Mol Med. 2019 Oct;11(10):e10124. doi: 10.15252/emmm.201810124. Epub 2019 Jun 6.
|
| 155 |
Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression.Hepatology. 2019 May;69(5):1946-1964. doi: 10.1002/hep.30485.
|
| 156 |
Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice.Hepatology. 2019 Feb;69(2):524-544. doi: 10.1002/hep.29820. Epub 2018 May 15.
|
| 157 |
Metabolic profiling of ob/ob mouse fatty liver using HR-MAS (1)H-NMR combined with gene expression analysis reveals alterations in betaine metabolism and the transsulfuration pathway.Anal Bioanal Chem. 2017 Feb;409(6):1591-1606. doi: 10.1007/s00216-016-0100-1. Epub 2016 Nov 28.
|
| 158 |
A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models.Eur J Pharmacol. 2017 Feb 5;796:45-53. doi: 10.1016/j.ejphar.2016.12.018. Epub 2016 Dec 13.
|
| 159 |
Modulation of Tetrachloroethylene-Associated Kidney Effects by Nonalcoholic Fatty Liver or Steatohepatitis in Male C57BL/6J Mice.Toxicol Sci. 2019 Jan 1;167(1):126-137. doi: 10.1093/toxsci/kfy223.
|
| 160 |
AAV-mediated administration of myostatin pro-peptide mutant in adult Ldlr null mice reduces diet-induced hepatosteatosis and arteriosclerosis.PLoS One. 2013 Aug 1;8(8):e71017. doi: 10.1371/journal.pone.0071017. Print 2013.
|
| 161 |
SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease.Cell Rep. 2013 Nov 14;5(3):654-665. doi: 10.1016/j.celrep.2013.10.007. Epub 2013 Nov 7.
|
| 162 |
Proteomic Analysis Reveals Novel Mechanisms by Which Polychlorinated Biphenyls Compromise the Liver Promoting Diet-Induced Steatohepatitis.J Proteome Res. 2019 Apr 5;18(4):1582-1594. doi: 10.1021/acs.jproteome.8b00886. Epub 2019 Mar 15.
|
| 163 |
The Long Non-coding RNA MEG3/miR-let-7c-5p Axis Regulates Ethanol-Induced Hepatic Steatosis and Apoptosis by Targeting NLRC5.Front Pharmacol. 2018 Apr 10;9:302. doi: 10.3389/fphar.2018.00302. eCollection 2018.
|
| 164 |
Deletion of NLRX1 increases fatty acid metabolism and prevents diet-induced hepatic steatosis and metabolic syndrome.Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1883-1895. doi: 10.1016/j.bbadis.2018.03.003. Epub 2018 Mar 4.
|
| 165 |
Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, -3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter.Curr Pharm Des. 2017;23(27):3941-3951. doi: 10.2174/1381612823666170714124824.
|
| 166 |
Overexpression of C-type Natriuretic Peptide in Endothelial Cells Protects against Insulin Resistance and Inflammation during Diet-induced Obesity.Sci Rep. 2017 Aug 29;7(1):9807. doi: 10.1038/s41598-017-10240-1.
|
| 167 |
REV-ERB Activates C/EBP Homologous Protein to Control Small Heterodimer Partner-Mediated Oscillation of Alcoholic Fatty Liver.Am J Pathol. 2016 Nov;186(11):2909-2920. doi: 10.1016/j.ajpath.2016.07.014. Epub 2016 Sep 21.
|
| 168 |
Ursolic Acid, a Novel Liver X Receptor (LXR) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.J Agric Food Chem. 2018 Nov 7;66(44):11647-11662. doi: 10.1021/acs.jafc.8b04116. Epub 2018 Oct 25.
|
| 169 |
Pregnane X receptor mediates steatotic effects of propiconazole and tebuconazole in human liver cell lines. Arch Toxicol. 2019 May;93(5):1311-1322.
|
| 170 |
Transplantation of neuregulin 4-overexpressing adipose-derived mesenchymal stem cells ameliorates insulin resistance by attenuating hepatic steatosis.Exp Biol Med (Maywood). 2019 May;244(7):565-578. doi: 10.1177/1535370219839643. Epub 2019 Apr 1.
|
| 171 |
Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.Cancer Sci. 2015 Sep;106(9):1143-52. doi: 10.1111/cas.12730. Epub 2015 Sep 1.
|
| 172 |
Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis.Sci Rep. 2018 Oct 24;8(1):15711. doi: 10.1038/s41598-018-34148-6.
|
| 173 |
The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosis.J Lipid Res. 2017 Feb;58(2):420-432. doi: 10.1194/jlr.M073734. Epub 2016 Dec 10.
|
| 174 |
The clinical spectrum of inherited diseases involved in the synthesis and remodeling of complex lipids. A tentative overview.J Inherit Metab Dis. 2015 Jan;38(1):19-40. doi: 10.1007/s10545-014-9776-6. Epub 2014 Nov 21.
|
| 175 |
Role of PTP1B in POMC neurons during chronic high-fat diet: sex differences in regulation of liver lipids and glucose tolerance.Am J Physiol Regul Integr Comp Physiol. 2018 Mar 1;314(3):R478-R488. doi: 10.1152/ajpregu.00287.2017. Epub 2017 Dec 20.
|
| 176 |
Serum concentrations of trace elements and their relationships with paraoxonase-1 in morbidly obese women.J Trace Elem Med Biol. 2018 Jul;48:8-15. doi: 10.1016/j.jtemb.2018.02.023. Epub 2018 Mar 1.
|
| 177 |
PPAR attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation.Cell Death Dis. 2019 Feb 27;10(3):197. doi: 10.1038/s41419-019-1458-8.
|
| 178 |
Cyclophilin D deficiency attenuates mitochondrial perturbation and ameliorates hepatic steatosis.Hepatology. 2018 Jul;68(1):62-77. doi: 10.1002/hep.29788. Epub 2018 May 9.
|
| 179 |
Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease.Pathol Int. 2018 Feb;68(2):91-101. doi: 10.1111/pin.12634. Epub 2018 Jan 17.
|
| 180 |
Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line.PLoS One. 2016 Oct 19;11(10):e0165224. doi: 10.1371/journal.pone.0165224. eCollection 2016.
|
| 181 |
Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in apoE knockout mice.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1402-1409. doi: 10.1016/j.bbadis.2019.02.012. Epub 2019 Feb 15.
|
| 182 |
Mice depleted for Exchange Proteins Directly Activated by cAMP (Epac) exhibit irregular liver regeneration in response to partial hepatectomy.Sci Rep. 2019 Sep 24;9(1):13789. doi: 10.1038/s41598-019-50219-8.
|
| 183 |
Adipocyte-specific expression of a retinoic acid receptor dominant negative form causes glucose intolerance and hepatic steatosis in mice.Biochem Biophys Res Commun. 2019 Jul 5;514(4):1231-1237. doi: 10.1016/j.bbrc.2019.05.075. Epub 2019 May 17.
|
| 184 |
Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis. J Med Chem. 2019 Jun 13;62(11):5470-5500.
|
| 185 |
A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE.PLoS One. 2019 May 22;14(5):e0216736. doi: 10.1371/journal.pone.0216736. eCollection 2019.
|
| 186 |
Liver-specific deletion of ROR aggravates diet-induced nonalcoholic steatohepatitis by inducing mitochondrial dysfunction.Sci Rep. 2017 Nov 22;7(1):16041. doi: 10.1038/s41598-017-16077-y.
|
| 187 |
SCD1 regulates the AMPK/SIRT1 pathway and histone acetylation through changes in adenine nucleotide metabolism in skeletal muscle.J Cell Physiol. 2020 Feb;235(2):1129-1140. doi: 10.1002/jcp.29026. Epub 2019 Jun 26.
|
| 188 |
Controlling Obesity and Metabolic Diseases by Hydrodynamic Delivery of a Fusion Gene of Exendin-4 and 1 Antitrypsin.Sci Rep. 2019 Sep 17;9(1):13427. doi: 10.1038/s41598-019-49757-y.
|
| 189 |
Characterization of chemically induced liver injuries using gene co-expression modules.PLoS One. 2014 Sep 16;9(9):e107230. doi: 10.1371/journal.pone.0107230. eCollection 2014.
|
| 190 |
Liver Disease in a Residential Cohort With Elevated Polychlorinated Biphenyl Exposures.Toxicol Sci. 2018 Jul 1;164(1):39-49. doi: 10.1093/toxsci/kfy076.
|
| 191 |
Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.J Clin Invest. 2010 Dec;120(12):4316-31. doi: 10.1172/JCI41624. Epub 2010 Nov 15.
|
| 192 |
microRNA-141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP-activated protein kinase pathway in hepatocytes.J Cell Physiol. 2020 Feb;235(2):880-890. doi: 10.1002/jcp.29002. Epub 2019 Jun 29.
|
| 193 |
Deacetylation of XBP1s by sirtuin 6 confers resistance to ER stress-induced hepatic steatosis.Exp Mol Med. 2019 Sep 20;51(9):1-11. doi: 10.1038/s12276-019-0309-0.
|
| 194 |
The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease.Ann Hepatol. 2015 Jul-Aug;14(4):487-93.
|
| 195 |
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation.Hepatology. 2020 Apr;71(4):1213-1227. doi: 10.1002/hep.30908. Epub 2020 Jan 24.
|
| 196 |
The longevity gene INDY (I'm Not Dead Yet) in metabolic control: Potential as pharmacological target.Pharmacol Ther. 2018 May;185:1-11. doi: 10.1016/j.pharmthera.2017.10.003. Epub 2017 Oct 5.
|
| 197 |
Expression of Glutamate Transporters in Mouse Liver, Kidney, and Intestine.J Histochem Cytochem. 2018 Mar;66(3):189-202. doi: 10.1369/0022155417749828. Epub 2018 Jan 5.
|
| 198 |
Palmitate activation by fatty acid transport protein 4 as a model system for hepatocellular apoptosis and steatosis.Biochim Biophys Acta. 2015 May;1851(5):549-65. doi: 10.1016/j.bbalip.2015.01.004. Epub 2015 Jan 17.
|
| 199 |
CD98 siRNA-loaded nanoparticles decrease hepatic steatosis in mice.Dig Liver Dis. 2017 Feb;49(2):188-196. doi: 10.1016/j.dld.2016.11.008. Epub 2016 Nov 17.
|
| 200 |
Epigenome-Wide Association Study Identifies Methylation Sites Associated With Liver Enzymes and Hepatic Steatosis.Gastroenterology. 2017 Oct;153(4):1096-1106.e2. doi: 10.1053/j.gastro.2017.06.003. Epub 2017 Jun 15.
|
| 201 |
Genetic depletion of Soat2 diminishes hepatic steatosis via genes regulating de novo lipogenesis and by GLUT2 protein in female mice.Dig Liver Dis. 2019 Jul;51(7):1016-1022. doi: 10.1016/j.dld.2018.12.007. Epub 2018 Dec 23.
|
| 202 |
Double Knockout of Peroxiredoxin 4 (Prdx4) and Superoxide Dismutase 1 (Sod1) in Mice Results in Severe Liver Failure.Oxid Med Cell Longev. 2018 Jun 27;2018:2812904. doi: 10.1155/2018/2812904. eCollection 2018.
|
| 203 |
Hepatocyte sortilin 1 knockout and treatment with a sortilin 1 inhibitor reduced plasma cholesterol in Western diet-fed mice.J Lipid Res. 2019 Mar;60(3):539-549. doi: 10.1194/jlr.M089789. Epub 2019 Jan 22.
|
| 204 |
Regulation and function of sphingosine kinase 2 in diseases.Histol Histopathol. 2018 May;33(5):433-445. doi: 10.14670/HH-11-939. Epub 2017 Oct 19.
|
| 205 |
Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.Obes Surg. 2017 Sep;27(9):2347-2353. doi: 10.1007/s11695-017-2606-9.
|
| 206 |
Bisphenol A exposure induces cholesterol synthesis and hepatic steatosis in C57BL/6 mice by down-regulating the DNA methylation levels of SREBP-2.Food Chem Toxicol. 2019 Nov;133:110786. doi: 10.1016/j.fct.2019.110786. Epub 2019 Aug 27.
|
| 207 |
Steroidogenic acute regulatory protein (StAR) overexpression attenuates HFD-induced hepatic steatosis and insulin resistance.Biochim Biophys Acta Mol Basis Dis. 2017 Apr;1863(4):978-990. doi: 10.1016/j.bbadis.2017.01.026. Epub 2017 Jan 30.
|
| 208 |
Stanniocalcin 2 Ameliorates Hepatosteatosis Through Activation of STAT3 Signaling.Front Physiol. 2018 Jul 9;9:873. doi: 10.3389/fphys.2018.00873. eCollection 2018.
|
| 209 |
Hepatic overexpression of steroid sulfatase ameliorates mouse models of obesity and type 2 diabetes through sex-specific mechanisms.J Biol Chem. 2014 Mar 21;289(12):8086-97. doi: 10.1074/jbc.M113.535914. Epub 2014 Feb 4.
|
| 210 |
LY2405319, an analog of fibroblast growth factor 21 ameliorates -smooth muscle actin production through inhibition of the succinate-G-protein couple receptor 91 (GPR91) pathway in mice.PLoS One. 2018 Feb 14;13(2):e0192146. doi: 10.1371/journal.pone.0192146. eCollection 2018.
|
| 211 |
ER-associated ubiquitin ligase HRD1 programs liver metabolism by targeting multiple metabolic enzymes.Nat Commun. 2018 Sep 10;9(1):3659. doi: 10.1038/s41467-018-06091-7.
|
| 212 |
Inhibition of IKK and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes.Cell Metab. 2017 Jul 5;26(1):157-170.e7. doi: 10.1016/j.cmet.2017.06.006.
|
| 213 |
Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia.Cell Metab. 2011 Apr 6;13(4):389-400. doi: 10.1016/j.cmet.2011.02.011.
|
| 214 |
Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet.Am J Pathol. 2011 Nov;179(5):2278-89. doi: 10.1016/j.ajpath.2011.07.015. Epub 2011 Sep 9.
|
| 215 |
New insights into regulation of lipid metabolism by thyroid hormone.Curr Opin Endocrinol Diabetes Obes. 2010 Oct;17(5):408-13. doi: 10.1097/MED.0b013e32833d6d46.
|
| 216 |
Hepatocyte-Specific Deletion of TIPARP, a Negative Regulator of the Aryl Hydrocarbon Receptor, Is Sufficient to Increase Sensitivity to Dioxin-Induced Wasting Syndrome.Toxicol Sci. 2018 Oct 1;165(2):347-360. doi: 10.1093/toxsci/kfy136.
|
| 217 |
Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE(-/-) mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-B inflammation.Nutr Metab (Lond). 2019 Nov 15;16:79. doi: 10.1186/s12986-019-0410-3. eCollection 2019.
|
| 218 |
Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease.Int J Mol Sci. 2016 Nov 10;17(11):1878. doi: 10.3390/ijms17111878.
|
| 219 |
Toll-like receptor 8 (TLR8) polymorphisms are associated with non-progression of chronic hepatitis C in HIV/HCV coinfected patients.Infect Genet Evol. 2015 Dec;36:339-344. doi: 10.1016/j.meegid.2015.10.006. Epub 2015 Oct 9.
|
| 220 |
B-Cell Activating Factor Enhances Hepatocyte-Driven Angiogenesis via B-Cell CLL/Lymphoma 10/Nuclear Factor-KappaB Signaling during Liver Regeneration.Int J Mol Sci. 2019 Oct 10;20(20):5022. doi: 10.3390/ijms20205022.
|
| 221 |
TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice.J Hepatol. 2015 Feb;62(2):371-9. doi: 10.1016/j.jhep.2014.09.026. Epub 2014 Oct 2.
|
| 222 |
Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study.Acta Histochem. 2018 Apr;120(3):242-254. doi: 10.1016/j.acthis.2018.02.006. Epub 2018 Feb 23.
|
| 223 |
Brown fat activation mitigates alcohol-induced liver steatosis and injury in mice.J Clin Invest. 2019 Mar 19;129(6):2305-2317. doi: 10.1172/JCI124376.
|
| 224 |
Oxidative stress and mitochondrial uncoupling protein 2 expression in hepatic steatosis induced by exposure to xenobiotic DDE and high fat diet in male Wistar rats.PLoS One. 2019 Apr 25;14(4):e0215955. doi: 10.1371/journal.pone.0215955. eCollection 2019.
|
| 225 |
Sphingolipids and hepatic steatosis.Adv Exp Med Biol. 2011;721:87-97. doi: 10.1007/978-1-4614-0650-1_6.
|
| 226 |
Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p.Gene. 2019 Jun 5;700:139-148. doi: 10.1016/j.gene.2019.02.096. Epub 2019 Mar 18.
|
| 227 |
A Mitochondrial VDAC1-Based Peptide Greatly Suppresses Steatosis and NASH-Associated Pathologies in a Mouse Model.Mol Ther. 2019 Oct 2;27(10):1848-1862. doi: 10.1016/j.ymthe.2019.06.017. Epub 2019 Jul 12.
|
| 228 |
RNA-binding protein ZFP36L1 maintains posttranscriptional regulation of bile acid metabolism.J Clin Invest. 2017 Oct 2;127(10):3741-3754. doi: 10.1172/JCI94029. Epub 2017 Sep 11.
|
| 229 |
Dihydromyricetin modulates p62 and autophagy crosstalk with the Keap-1/Nrf2 pathway to alleviate ethanol-induced hepatic injury.Toxicol Lett. 2017 May 15;274:31-41. doi: 10.1016/j.toxlet.2017.04.009. Epub 2017 Apr 15.
|
| 230 |
Type 2 Diabetes Variants in the SLC16A11 Coding Region Are Not Loss-of-Function Mutations.Cell Rep. 2019 Oct 15;29(3):781-784. doi: 10.1016/j.celrep.2019.09.022.
|
| 231 |
Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease.J Hepatol. 2008 Nov;49(5):810-20. doi: 10.1016/j.jhep.2008.05.016. Epub 2008 Jun 10.
|
| 232 |
Orphan nuclear receptor NR4A1 suppresses hyperhomocysteinemia-induced hepatic steatosis invitro and invivo.FEBS Lett. 2019 May;593(10):1061-1071. doi: 10.1002/1873-3468.13384. Epub 2019 Apr 22.
|
| 233 |
A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis.Horm Metab Res. 2010 Nov;42(12):854-9. doi: 10.1055/s-0030-1267186. Epub 2010 Oct 13.
|
| 234 |
Hepatic ZIP14-mediated zinc transport is required for adaptation to endoplasmic reticulum stress.Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5805-E5814. doi: 10.1073/pnas.1704012114. Epub 2017 Jul 3.
|
| 235 |
Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease.PLoS One. 2018 Oct 31;13(10):e0205747. doi: 10.1371/journal.pone.0205747. eCollection 2018.
|
| 236 |
Mild Methylenetetrahydrofolate Reductase Deficiency Alters Inflammatory and Lipid Pathways in Liver.Mol Nutr Food Res. 2019 Feb;63(3):e1801001. doi: 10.1002/mnfr.201801001. Epub 2018 Nov 23.
|
| 237 |
Thioesterase superfamily member 2 promotes hepatic insulin resistance in the setting of glycerol-3-phosphate acyltransferase 1-induced steatosis.J Biol Chem. 2019 Feb 8;294(6):2009-2020. doi: 10.1074/jbc.RA118.005184. Epub 2018 Dec 6.
|
| 238 |
Augmenter of liver regeneration protein deficiency promotes hepatic steatosis by inducing oxidative stress and microRNA-540 expression.FASEB J. 2019 Mar;33(3):3825-3840. doi: 10.1096/fj.201802015R. Epub 2018 Dec 12.
|
| 239 |
AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease.Metabolism. 2019 Oct;99:67-80. doi: 10.1016/j.metabol.2019.153947. Epub 2019 Jul 19.
|
| 240 |
Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance.Cell Rep. 2017 Jan 17;18(3):636-646. doi: 10.1016/j.celrep.2016.12.070.
|
| 241 |
Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity.Clin Gastroenterol Hepatol. 2007 Mar;5(3):388-93. doi: 10.1016/j.cgh.2006.12.021.
|
| 242 |
Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease.Toxicol Appl Pharmacol. 2013 Apr 15;268(2):132-40. doi: 10.1016/j.taap.2013.01.022. Epub 2013 Feb 4.
|
| 243 |
Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice.FASEB J. 2018 Jul;32(7):3792-3802. doi: 10.1096/fj.201701084RR. Epub 2018 Feb 26.
|
| 244 |
Dimethylarginine Dimethylaminohydrolase 1 Protects Against High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice.Antioxid Redox Signal. 2017 Apr 10;26(11):598-609. doi: 10.1089/ars.2016.6742. Epub 2016 Oct 20.
|
| 245 |
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients.J Viral Hepat. 2013 Jul;20(7):486-93. doi: 10.1111/jvh.12072. Epub 2013 Mar 25.
|
| 246 |
A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.PLoS One. 2016 May 2;11(5):e0154676. doi: 10.1371/journal.pone.0154676. eCollection 2016.
|
| 247 |
In a pilot study, reduced fatty acid desaturase 1 function was associated with nonalcoholic fatty liver disease and response to treatment in children.Pediatr Res. 2018 Nov;84(5):696-703. doi: 10.1038/s41390-018-0132-7. Epub 2018 Aug 4.
|
| 248 |
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.Gastroenterology. 2017 May;152(6):1449-1461.e7. doi: 10.1053/j.gastro.2017.01.015. Epub 2017 Jan 26.
|
| 249 |
Hepatic overexpression of methionine sulfoxide reductase A reduces atherosclerosis in apolipoprotein E-deficient mice.J Lipid Res. 2015 Oct;56(10):1891-900. doi: 10.1194/jlr.M058776. Epub 2015 Aug 28.
|
| 250 |
Evaluation of the therapeutic potential effect of Fas receptor gene knockdown in experimental model of non-alcoholic steatohepatitis.Free Radic Res. 2019 May;53(5):486-496. doi: 10.1080/10715762.2019.1608982. Epub 2019 May 7.
|
| 251 |
Overexpression of NRK1 ameliorates diet- and age-induced hepatic steatosis and insulin resistance.Biochem Biophys Res Commun. 2018 Jun 2;500(2):476-483. doi: 10.1016/j.bbrc.2018.04.107.
|
| 252 |
NNMT activation can contribute to the development of fatty liver disease by modulating the NAD (+) metabolism.Sci Rep. 2018 Jun 5;8(1):8637. doi: 10.1038/s41598-018-26882-8.
|
| 253 |
Lipogenic SREBP-1a/c transcription factors activate expression of the iron regulator hepcidin, revealing cross-talk between lipid and iron metabolisms.J Biol Chem. 2019 Aug 23;294(34):12743-12753. doi: 10.1074/jbc.RA119.009644. Epub 2019 Jul 3.
|
| 254 |
Hyodeoxycholic acid derivatives as liver X receptor and G-protein-coupled bile acid receptor agonists.Sci Rep. 2017 Feb 24;7:43290. doi: 10.1038/srep43290.
|
| 255 |
Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages.Atherosclerosis. 2013 May;228(1):124-35. doi: 10.1016/j.atherosclerosis.2013.02.026. Epub 2013 Mar 4.
|
| 256 |
Biliary drainage as treatment for allograft steatosis following liver transplantation for PFIC-1 disease: A single-center experience.Pediatr Transplant. 2018 Jun;22(4):e13184. doi: 10.1111/petr.13184. Epub 2018 Apr 14.
|
| 257 |
Do differences exist between chronic hepatitis C genotypes 2 and 3?.Rev Soc Bras Med Trop. 2014 Mar-Apr;47(2):143-8. doi: 10.1590/0037-8682-0269-2013.
|
| 258 |
Independent modes of disease repair by AIM protein distinguished in AIM-felinized mice.Sci Rep. 2018 Sep 3;8(1):13157. doi: 10.1038/s41598-018-31580-6.
|
| 259 |
The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children.Int J Mol Sci. 2019 Jul 14;20(14):3460. doi: 10.3390/ijms20143460.
|
| 260 |
Fat-specific protein 27b is regulated by hepatic peroxisome proliferator-activated receptor in hepatic steatosis.Endocr J. 2020 Jan 28;67(1):37-44. doi: 10.1507/endocrj.EJ19-0296. Epub 2019 Sep 27.
|
| 261 |
Diet-induced hepatic steatosis activates Ras to promote hepatocarcinogenesis via CPT1.Cancer Lett. 2019 Feb 1;442:40-52. doi: 10.1016/j.canlet.2018.10.024. Epub 2018 Oct 26.
|
| 262 |
Discovery of a role of the novel hepatokine, hepassocin, in obesity.Biofactors. 2020 Jan;46(1):100-105. doi: 10.1002/biof.1574. Epub 2019 Oct 6.
|
| 263 |
Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes.Diabetes Obes Metab. 2020 Mar;22(3):393-403. doi: 10.1111/dom.13907. Epub 2019 Dec 14.
|
| 264 |
NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects.Hum Mol Genet. 2018 Jun 15;27(12):2214-2223. doi: 10.1093/hmg/ddy124.
|
| 265 |
Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease.J Gastroenterol Hepatol. 2010 Feb;25(2):357-61. doi: 10.1111/j.1440-1746.2009.06001.x. Epub 2009 Oct 9.
|
| 266 |
The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis.Hepatology. 2017 May;65(5):1492-1511. doi: 10.1002/hep.28971. Epub 2017 Mar 22.
|
| 267 |
Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).PLoS One. 2017 Jun 8;12(6):e0178685. doi: 10.1371/journal.pone.0178685. eCollection 2017.
|
| 268 |
Mice lacking RAP1 show early onset and higher rates of DEN-induced hepatocellular carcinomas in female mice.PLoS One. 2018 Oct 11;13(10):e0204909. doi: 10.1371/journal.pone.0204909. eCollection 2018.
|
| 269 |
Retinol saturase coordinates liver metabolism by regulating ChREBP activity.Nat Commun. 2017 Aug 30;8(1):384. doi: 10.1038/s41467-017-00430-w.
|
| 270 |
Sfrp5 interacts with Slurp1 to regulate the accumulation of triglycerides in hepatocyte steatosis model.Biochem Biophys Res Commun. 2019 Apr 30;512(2):256-262. doi: 10.1016/j.bbrc.2019.03.035. Epub 2019 Mar 15.
|
| 271 |
Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.Diabetes. 2017 May;66(5):1185-1197. doi: 10.2337/db16-0993. Epub 2017 Feb 28.
|
| 272 |
Trefoil factor expression in biliary epithelium of graft-versus-host disease of the liver after allogeneic hematopoietic cell transplantation.Transplantation. 2005 Oct 27;80(8):1099-104. doi: 10.1097/01.tp.0000179151.55881.a7.
|
| 273 |
MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis.Int J Biol Macromol. 2019 Dec 1;141:1013-1021. doi: 10.1016/j.ijbiomac.2019.09.007. Epub 2019 Sep 3.
|
| 274 |
IGF2 mRNA Binding Protein 2 Transgenic Mice Are More Prone to Develop a Ductular Reaction and to Progress Toward Cirrhosis.Front Med (Lausanne). 2019 Sep 4;6:179. doi: 10.3389/fmed.2019.00179. eCollection 2019.
|
| 275 |
Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice.Biomed Res Int. 2019 Jun 19;2019:6740616. doi: 10.1155/2019/6740616. eCollection 2019.
|
| 276 |
Identification of Potential Plasma Biomarkers for Nonalcoholic Fatty Liver Disease by Integrating Transcriptomics and Proteomics in Laying Hens.J Nutr. 2017 Mar;147(3):293-303. doi: 10.3945/jn.116.240358. Epub 2017 Jan 11.
|
| 277 |
Liver cirrhosis in an infant with Chanarin-Dorfman syndrome caused by a novel splice-site mutation in ABHD5.Acta Paediatr. 2010 Oct;99(10):1592-4. doi: 10.1111/j.1651-2227.2010.01869.x.
|
| 278 |
Early onset of Chanarin-Dorfman syndrome with severe liver involvement in a patient with a complex rearrangement of ABHD5 promoter.BMC Med Genet. 2014 Mar 14;15:32. doi: 10.1186/1471-2350-15-32.
|
| 279 |
Combination of postmortem mass spectrometry imaging and genetic analysis reveals very long-chain acyl-CoA dehydrogenase deficiency in a case of infant death with liver steatosis.Forensic Sci Int. 2014 Nov;244:e34-7. doi: 10.1016/j.forsciint.2014.08.031. Epub 2014 Sep 6.
|
| 280 |
circRNA_0046367 Prevents Hepatoxicity of Lipid Peroxidation: An Inhibitory Role against Hepatic Steatosis.Oxid Med Cell Longev. 2017;2017:3960197. doi: 10.1155/2017/3960197. Epub 2017 Sep 5.
|
| 281 |
Regulation of fatty acid trafficking in liver by thioesterase superfamily member 1.J Lipid Res. 2018 Feb;59(2):368-379. doi: 10.1194/jlr.M081455. Epub 2017 Dec 5.
|
| 282 |
Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice.Hepatology. 2019 Mar;69(3):1105-1121. doi: 10.1002/hep.30249. Epub 2019 Feb 12.
|
| 283 |
Lipid-induced up-regulation of human acyl-CoA synthetase 5 promotes hepatocellular apoptosis.Biochim Biophys Acta. 2010 Sep;1801(9):1025-35. doi: 10.1016/j.bbalip.2010.04.010. Epub 2010 May 12.
|
| 284 |
Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis.Mol Metab. 2017 Jan 12;6(3):267-275. doi: 10.1016/j.molmet.2017.01.002. eCollection 2017 Mar.
|
| 285 |
Angiogenic factor with G patch and FHA domains 1 (Aggf1) promotes hepatic steatosis in mice.Biochem Biophys Res Commun. 2017 Jan 1;482(1):134-140. doi: 10.1016/j.bbrc.2016.10.071. Epub 2016 Nov 16.
|
| 286 |
Sugary Kefir Strain Lactobacillus mali APS1 Ameliorated Hepatic Steatosis by Regulation of SIRT-1/Nrf-2 and Gut Microbiota in Rats.Mol Nutr Food Res. 2018 Apr;62(8):e1700903. doi: 10.1002/mnfr.201700903. Epub 2018 Apr 3.
|
| 287 |
A Next Generation Sequencing custom gene panel as first line diagnostic tool for atypical cases of syndromic obesity: Application in a case of Alstrm syndrome.Eur J Med Genet. 2018 Feb;61(2):79-83. doi: 10.1016/j.ejmg.2017.10.016. Epub 2017 Oct 24.
|
| 288 |
Hepatocyte ALOXE3 is induced during adaptive fasting and enhances insulin sensitivity by activating hepatic PPAR.JCI Insight. 2018 Aug 23;3(16):e120794. doi: 10.1172/jci.insight.120794. eCollection 2018 Aug 23.
|
| 289 |
Role of glycoprotein 78 and cidec in hepatic steatosis.Mol Med Rep. 2017 Aug;16(2):1871-1877. doi: 10.3892/mmr.2017.6834. Epub 2017 Jun 21.
|
| 290 |
Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver.PLoS One. 2012;7(11):e48801. doi: 10.1371/journal.pone.0048801. Epub 2012 Nov 9.
|
| 291 |
Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.Diabetologia. 2018 Jun;61(6):1435-1446. doi: 10.1007/s00125-018-4579-1. Epub 2018 Mar 1.
|
| 292 |
Human hepatic 3D spheroids as a model for steatosis and insulin resistance.Sci Rep. 2018 Sep 24;8(1):14297. doi: 10.1038/s41598-018-32722-6.
|
| 293 |
Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance.J Lipid Res. 2004 Jan;45(1):9-16. doi: 10.1194/jlr.M300240-JLR200. Epub 2003 Oct 1.
|
| 294 |
Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis.J Hepatol. 2008 Nov;49(5):787-98. doi: 10.1016/j.jhep.2008.06.029. Epub 2008 Sep 7.
|
| 295 |
Autophagy dysregulation caused by ApoM deficiency plays an important role in liver lipid metabolic disorder.Biochem Biophys Res Commun. 2018 Jan 22;495(4):2643-2648. doi: 10.1016/j.bbrc.2017.12.148. Epub 2017 Dec 27.
|
| 296 |
Role of aquaporin-7 in ghrelin- and GLP-1-induced improvement of pancreatic -cell function after sleeve gastrectomy in obese rats.Int J Obes (Lond). 2017 Sep;41(9):1394-1402. doi: 10.1038/ijo.2017.135. Epub 2017 Jun 6.
|
| 297 |
A specific amino acid formula prevents alcoholic liver disease in rodents.Am J Physiol Gastrointest Liver Physiol. 2018 May 1;314(5):G566-G582. doi: 10.1152/ajpgi.00231.2017. Epub 2018 Jan 25.
|
| 298 |
Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis.PLoS One. 2019 Dec 4;14(12):e0225332. doi: 10.1371/journal.pone.0225332. eCollection 2019.
|
| 299 |
Loss of the Mono-ADP-ribosyltransferase, Tiparp, Increases Sensitivity to Dioxin-induced Steatohepatitis and Lethality.J Biol Chem. 2015 Jul 3;290(27):16824-40. doi: 10.1074/jbc.M115.660100. Epub 2015 May 13.
|
| 300 |
Age modulates liver responses to asparaginase-induced amino acid stress in mice.J Biol Chem. 2019 Sep 20;294(38):13864-13875. doi: 10.1074/jbc.RA119.009864. Epub 2019 Aug 14.
|
| 301 |
Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping.Eur Radiol. 2019 Jul;29(7):3791-3801. doi: 10.1007/s00330-019-06150-7. Epub 2019 Apr 1.
|
| 302 |
Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes.FEBS Lett. 2011 May 6;585(9):1338-44. doi: 10.1016/j.febslet.2011.04.003. Epub 2011 Apr 7.
|
| 303 |
Murine CD103(+) dendritic cells protect against steatosis progression towards steatohepatitis.J Hepatol. 2017 Jun;66(6):1241-1250. doi: 10.1016/j.jhep.2017.01.008. Epub 2017 Jan 18.
|
| 304 |
Hepatocyte-specific deletion of BAP31 promotes SREBP1C activation, promotes hepatic lipid accumulation, and worsens IR in mice.J Lipid Res. 2018 Jan;59(1):35-47. doi: 10.1194/jlr.M077016. Epub 2017 Nov 7.
|
| 305 |
Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in Mice.Mol Nutr Food Res. 2018 Apr;62(8):e1700738. doi: 10.1002/mnfr.201700738. Epub 2018 Mar 22.
|
| 306 |
Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas.J Biol Chem. 2011 Oct 21;286(42):36258-67. doi: 10.1074/jbc.M111.265348. Epub 2011 Aug 30.
|
| 307 |
Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function.Nat Commun. 2017 Sep 7;8(1):480. doi: 10.1038/s41467-017-00566-9.
|
| 308 |
Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy.J Pharmacol Sci. 2018 Apr;136(4):189-195. doi: 10.1016/j.jphs.2017.11.007. Epub 2017 Dec 1.
|
| 309 |
SEIPIN overexpression in the liver may alleviate hepatic steatosis by influencing the intracellular calcium level.Mol Cell Endocrinol. 2019 May 15;488:70-78. doi: 10.1016/j.mce.2019.03.005. Epub 2019 Mar 12.
|
| 310 |
Myonectin deletion promotes adipose fat storage and reduces liver steatosis.FASEB J. 2019 Jul;33(7):8666-8687. doi: 10.1096/fj.201900520R. Epub 2019 Apr 19.
|
| 311 |
Caspase Recruitment Domain Protein 6 Protects Against Hepatic Steatosis and Insulin Resistance by Suppressing Apoptosis Signal-Regulating Kinase 1.Hepatology. 2018 Dec;68(6):2212-2229. doi: 10.1002/hep.30075. Epub 2018 Nov 15.
|
| 312 |
Congenital generalized lipodystrophy: The evaluation of clinical follow-up findings in a series of five patients with type 1 and two patients with type 4.Eur J Med Genet. 2020 Apr;63(4):103819. doi: 10.1016/j.ejmg.2019.103819. Epub 2019 Nov 25.
|
| 313 |
Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice.J Clin Invest. 2010 Feb;120(2):545-58. doi: 10.1172/JCI39319. Epub 2010 Jan 11.
|
| 314 |
Adipose tissue and serum CCDC80 in obesity and its association with related metabolic disease.Mol Med. 2017 Oct;23:225-234. doi: 10.2119/molmed.2017.00067. Epub 2017 Aug 23.
|
| 315 |
Atherogenic index of plasma is a novel and strong predictor associated with fatty liver: a cross-sectional study in the Chinese Han population.Lipids Health Dis. 2019 Sep 12;18(1):170. doi: 10.1186/s12944-019-1112-6.
|
| 316 |
Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance With Human Alcoholic Hepatitis.Toxicol Sci. 2019 Aug 1;170(2):427-437. doi: 10.1093/toxsci/kfy292.
|
| 317 |
Hepatocyte-specific deletion of LASS2 protects against diet-induced hepatic steatosis and insulin resistance.Free Radic Biol Med. 2018 May 20;120:330-341. doi: 10.1016/j.freeradbiomed.2018.04.003. Epub 2018 Apr 4.
|
| 318 |
CD2-Associated Protein Contributes to Hepatitis C, Virus Propagation and Steatosis by Disrupting Insulin Signaling.Hepatology. 2018 Nov;68(5):1710-1725. doi: 10.1002/hep.30073.
|
| 319 |
RNA Binding Protein CUGBP1 Inhibits Liver Cancer in a Phosphorylation-Dependent Manner.Mol Cell Biol. 2017 Jul 28;37(16):e00128-17. doi: 10.1128/MCB.00128-17. Print 2017 Aug 15.
|
| 320 |
A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis.FASEB J. 2018 Jan;32(1):130-142. doi: 10.1096/fj.201601142R. Epub 2017 Sep 1.
|
| 321 |
The adiponectin promoter activator NP-1 induces high levels of circulating TNF and weight loss in obese (fa/fa) Zucker rats.Sci Rep. 2018 Jun 29;8(1):9858. doi: 10.1038/s41598-018-27871-7.
|
| 322 |
The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent.Int J Mol Sci. 2014 Apr 25;15(5):7213-24. doi: 10.3390/ijms15057213.
|
| 323 |
Genetic resistance to liver fibrosis on A/J mouse chromosome 17.Alcohol Clin Exp Res. 2013 Oct;37(10):1668-79. doi: 10.1111/acer.12157. Epub 2013 Jun 13.
|
| 324 |
Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.Br J Dermatol. 2005 Mar;152(3):451-8. doi: 10.1111/j.1365-2133.2005.06459.x.
|
| 325 |
Transcriptional regulation of apolipoprotein A-IV by the transcription factor CREBH.J Lipid Res. 2014 May;55(5):850-9. doi: 10.1194/jlr.M045104. Epub 2014 Mar 5.
|
| 326 |
Hepatic CREBZF couples insulin to lipogenesis by inhibiting insig activity and contributes to hepatic steatosis in diet-induced insulin-resistant mice.Hepatology. 2018 Oct;68(4):1361-1375. doi: 10.1002/hep.29926. Epub 2018 May 18.
|
| 327 |
CREG1 heterozygous mice are susceptible to high fat diet-induced obesity and insulin resistance.PLoS One. 2017 May 1;12(5):e0176873. doi: 10.1371/journal.pone.0176873. eCollection 2017.
|
| 328 |
Endoplasmic reticulum stress in the livers of BDNF heterozygous knockout mice.Arch Physiol Biochem. 2019 Oct;125(4):378-386. doi: 10.1080/13813455.2018.1489850. Epub 2018 Jul 24.
|
| 329 |
Increased liver AGEs induce hepatic injury mediated through an OST48 pathway.Sci Rep. 2017 Sep 25;7(1):12292. doi: 10.1038/s41598-017-12548-4.
|
| 330 |
RNA helicase DDX3 maintains lipid homeostasis through upregulation of the microsomal triglyceride transfer protein by interacting with HNF4 and SHP.Sci Rep. 2017 Jan 27;7:41452. doi: 10.1038/srep41452.
|
| 331 |
High fructose-containing drinking water-induced steatohepatitis in rats is prevented by the nicotinamide-mediated modulation of redox homeostasis and NADPH-producing enzymes.Mol Biol Rep. 2020 Jan;47(1):337-351. doi: 10.1007/s11033-019-05136-4. Epub 2019 Oct 24.
|
| 332 |
Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.Metabolism. 2005 Nov;54(11):1490-8. doi: 10.1016/j.metabol.2005.05.015.
|
| 333 |
Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis.Biochem Pharmacol. 2010 Mar 1;79(5):792-9. doi: 10.1016/j.bcp.2009.10.011. Epub 2009 Oct 23.
|
| 334 |
pNaKtide Attenuates Steatohepatitis and Atherosclerosis by Blocking Na/K-ATPase/ROS Amplification in C57Bl6 and ApoE Knockout Mice Fed a Western Diet.Sci Rep. 2017 Mar 15;7(1):193. doi: 10.1038/s41598-017-00306-5.
|
| 335 |
Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal-Regulating Kinase 1 Pathways.Hepatology. 2019 Oct;70(4):1099-1118. doi: 10.1002/hep.30597. Epub 2019 Apr 22.
|
| 336 |
Soluble FGFR4 extracellular domain inhibits FGF19-induced activation of FGFR4 signaling and prevents nonalcoholic fatty liver disease.Biochem Biophys Res Commun. 2011 Jun 17;409(4):651-6. doi: 10.1016/j.bbrc.2011.05.059. Epub 2011 May 17.
|
| 337 |
Circulating ectodysplasin A is a potential biomarker for nonalcoholic fatty liver disease.Clin Chim Acta. 2019 Dec;499:134-141. doi: 10.1016/j.cca.2019.09.009. Epub 2019 Sep 14.
|
| 338 |
Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice.Diabetologia. 2018 Apr;61(4):919-931. doi: 10.1007/s00125-017-4520-z. Epub 2017 Dec 21.
|
| 339 |
Multi-SNP analysis of GWAS data identifies pathways associated with nonalcoholic fatty liver disease.PLoS One. 2013 Jul 19;8(7):e65982. doi: 10.1371/journal.pone.0065982. Print 2013.
|
| 340 |
Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.J Lipid Res. 2014 Jul;55(7):1448-64. doi: 10.1194/jlr.M050062. Epub 2014 May 9.
|
| 341 |
Lipidomic analysis of human primary hepatocytes following LXR activation with GW3965 identifies AGXT2L1 as a main target associated to changes in phosphatidylethanolamine.J Steroid Biochem Mol Biol. 2020 Apr;198:105558. doi: 10.1016/j.jsbmb.2019.105558. Epub 2019 Nov 26.
|
| 342 |
Hepatocyte-specific depletion of ubiquitin regulatory X domain containing protein 8 accelerates fibrosis in a mouse non-alcoholic steatohepatitis model.Histochem Cell Biol. 2017 Sep;148(3):219-227. doi: 10.1007/s00418-017-1572-6. Epub 2017 Apr 18.
|
| 343 |
Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway.Hepatology. 2011 Jun;53(6):1906-16. doi: 10.1002/hep.24295. Epub 2011 May 2.
|
| 344 |
Liver X receptor induces 17-hydroxysteroid dehydrogenase-13 expression through SREBP-1c.Am J Physiol Endocrinol Metab. 2017 Apr 1;312(4):E357-E367. doi: 10.1152/ajpendo.00310.2016. Epub 2017 Mar 7.
|
| 345 |
Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis.Hepatology. 2020 Mar;71(3):861-873. doi: 10.1002/hep.30867. Epub 2019 Oct 10.
|
| 346 |
Fetuin B aggravates liver X receptor-mediated hepatic steatosis through AMPK in HepG2 cells and mice.Am J Transl Res. 2019 Mar 15;11(3):1498-1509. eCollection 2019.
|
| 347 |
Activation and increase of radio-sensitive CD11b+ recruited Kupffer cells/macrophages in diet-induced steatohepatitis in FGF5 deficient mice.Sci Rep. 2016 Oct 6;6:34466. doi: 10.1038/srep34466.
|
| 348 |
A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR.J Hepatol. 2019 Mar;70(3):494-500. doi: 10.1016/j.jhep.2018.10.021. Epub 2018 Oct 31.
|
| 349 |
A simple transcriptomic signature able to predict drug-induced hepatic steatosis.Arch Toxicol. 2014 Apr;88(4):967-82. doi: 10.1007/s00204-014-1197-7. Epub 2014 Jan 28.
|
| 350 |
HCBP6 Is Involved in the Development of Hepatic Steatosis Induced by High-Fat Diet and CCL4 in Rats.Ann Hepatol. 2018 May-June;17(3):511-518. doi: 10.5604/01.3001.0011.7396. Epub 2018 Apr 9.
|
| 351 |
Activation of G0/G1 switch gene 2 by endoplasmic reticulum stress enhances hepatic steatosis.Metabolism. 2019 Oct;99:32-44. doi: 10.1016/j.metabol.2019.06.015. Epub 2019 Jul 2.
|
| 352 |
Deletion of Gab2 in mice protects against hepatic steatosis and steatohepatitis: a novel therapeutic target for fatty liver disease.J Mol Cell Biol. 2016 Dec;8(6):492-504. doi: 10.1093/jmcb/mjw028. Epub 2016 Jun 9.
|
| 353 |
A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease.J Formos Med Assoc. 2020 Jan;119(1 Pt 1):173-181. doi: 10.1016/j.jfma.2019.03.016. Epub 2019 Apr 11.
|
| 354 |
Dysregulated transmethylation leading to hepatocellular carcinoma compromises redox homeostasis and glucose formation.Mol Metab. 2019 May;23:1-13. doi: 10.1016/j.molmet.2019.02.006. Epub 2019 Feb 25.
|
| 355 |
Efficacy and safety of glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: A systematic review and meta-analysis.Clin Res Hepatol Gastroenterol. 2017 Jun;41(3):284-295. doi: 10.1016/j.clinre.2016.11.009. Epub 2017 Jan 5.
|
| 356 |
GP73 regulates Hepatic Steatosis by enhancing SCAP-SREBPs interaction.Sci Rep. 2017 Nov 2;7(1):14932. doi: 10.1038/s41598-017-06500-9.
|
| 357 |
Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPAR.Nat Commun. 2019 Apr 11;10(1):1684. doi: 10.1038/s41467-019-09524-z.
|
| 358 |
Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy.Mol Metab. 2015 Apr 21;4(6):493-506. doi: 10.1016/j.molmet.2015.04.001. eCollection 2015 Jun.
|
| 359 |
Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.J Hepatol. 2018 Apr;68(4):773-782. doi: 10.1016/j.jhep.2017.11.040. Epub 2017 Dec 20.
|
| 360 |
Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.Clin Endocrinol (Oxf). 2009 Apr;70(4):554-60. doi: 10.1111/j.1365-2265.2008.03358.x.
|
| 361 |
A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.N Engl J Med. 1999 Jun 3;340(22):1723-31. doi: 10.1056/NEJM199906033402204.
|
| 362 |
ENU mutagenesis identifies mice with cardiac fibrosis and hepatic steatosis caused by a mutation in the mitochondrial trifunctional protein beta-subunit.Hum Mol Genet. 2006 Dec 15;15(24):3569-77. doi: 10.1093/hmg/ddl433. Epub 2006 Nov 20.
|
| 363 |
Differential effects of hyaluronan synthase 3 deficiency after acute vs chronic liver injury in mice.Fibrogenesis Tissue Repair. 2016 Mar 31;9:4. doi: 10.1186/s13069-016-0041-5. eCollection 2016.
|
| 364 |
TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesis.Nat Commun. 2016 May 4;7:11379. doi: 10.1038/ncomms11379.
|
| 365 |
Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.Free Radic Biol Med. 2017 Dec;113:71-83. doi: 10.1016/j.freeradbiomed.2017.09.016. Epub 2017 Sep 21.
|
| 366 |
HSPA12A Is a Novel Player in Nonalcoholic Steatohepatitis via Promoting Nuclear PKM2-Mediated M1 Macrophage Polarization.Diabetes. 2019 Feb;68(2):361-376. doi: 10.2337/db18-0035. Epub 2018 Nov 19.
|
| 367 |
Impact of hepatic HSP72 on insulin signaling.Am J Physiol Endocrinol Metab. 2019 Feb 1;316(2):E305-E318. doi: 10.1152/ajpendo.00215.2018. Epub 2018 Dec 11.
|
| 368 |
Protectin DX Ameliorates Hepatic Steatosis by Suppression of Endoplasmic Reticulum Stress via AMPK-Induced ORP150 Expression.J Pharmacol Exp Ther. 2018 Jun;365(3):485-493. doi: 10.1124/jpet.117.246686. Epub 2018 Mar 23.
|
| 369 |
Cytoprotective Mechanisms in Fatty Liver Preservation against Cold Ischemia Injury: A Comparison between IGL-1 and HTK.Int J Mol Sci. 2018 Jan 24;19(2):348. doi: 10.3390/ijms19020348.
|
| 370 |
CXCR6 protects from inflammation and fibrosis in NEMO(LPC-KO) mice.Biochim Biophys Acta Mol Basis Dis. 2019 Feb 1;1865(2):391-402. doi: 10.1016/j.bbadis.2018.11.020. Epub 2018 Nov 24.
|
| 371 |
Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia.Hepatology. 2014 Aug;60(2):554-64. doi: 10.1002/hep.27153. Epub 2014 May 19.
|
| 372 |
INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis.World J Gastroenterol. 2018 Jan 14;24(2):195-210. doi: 10.3748/wjg.v24.i2.195.
|
| 373 |
Global IP6K1 deletion enhances temperature modulated energy expenditure which reduces carbohydrate and fat induced weight gain.Mol Metab. 2016 Nov 28;6(1):73-85. doi: 10.1016/j.molmet.2016.11.010. eCollection 2017 Jan.
|
| 374 |
Ablation of Iqgap2 protects from diet-induced hepatic steatosis due to impaired fatty acid uptake.Regul Pept. 2012 Jan 10;173(1-3):36-46. doi: 10.1016/j.regpep.2011.09.003. Epub 2011 Oct 1.
|
| 375 |
Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3.Hepatology. 2020 May;71(5):1592-1608. doi: 10.1002/hep.30950. Epub 2020 Jan 30.
|
| 376 |
Hepatic Interferon Regulatory Factor 6 Alleviates Liver Steatosis and Metabolic Disorder by Transcriptionally Suppressing Peroxisome Proliferator-Activated Receptor in Mice.Hepatology. 2019 Jun;69(6):2471-2488. doi: 10.1002/hep.30559. Epub 2019 Apr 22.
|
| 377 |
The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study.Liver Int. 2019 Jun;39(6):1022-1026. doi: 10.1111/liv.14039. Epub 2019 Feb 17.
|
| 378 |
JAZF1 ameliorates age and diet-associated hepatic steatosis through SREBP-1c -dependent mechanism.Cell Death Dis. 2018 Aug 28;9(9):859. doi: 10.1038/s41419-018-0923-0.
|
| 379 |
Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.Gastroenterology. 2017 Dec;153(6):1568-1580.e10. doi: 10.1053/j.gastro.2017.08.039. Epub 2017 Aug 30.
|
| 380 |
Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPAR2.Sci Rep. 2018 Sep 13;8(1):13734. doi: 10.1038/s41598-018-31953-x.
|
| 381 |
A Novel Y-Specific Long Non-Coding RNA Associated with Cellular Lipid Accumulation in HepG2 cells and Atherosclerosis-related Genes.Sci Rep. 2017 Dec 1;7(1):16710. doi: 10.1038/s41598-017-17165-9.
|
| 382 |
3-ketodihydrosphingosine reductase mutation induces steatosis and hepatic injury in zebrafish.Sci Rep. 2019 Feb 4;9(1):1138. doi: 10.1038/s41598-018-37946-0.
|
| 383 |
KLF15 is a molecular link between endoplasmic reticulum stress and insulin resistance.PLoS One. 2013 Oct 22;8(10):e77851. doi: 10.1371/journal.pone.0077851. eCollection 2013.
|
| 384 |
Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis.J Hepatol. 2013 May;58(5):1000-6. doi: 10.1016/j.jhep.2013.01.020. Epub 2013 Jan 23.
|
| 385 |
Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.Eur J Gastroenterol Hepatol. 2019 May;31(5):633-641. doi: 10.1097/MEG.0000000000001385.
|
| 386 |
Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis.PLoS One. 2012;7(10):e46584. doi: 10.1371/journal.pone.0046584. Epub 2012 Oct 10.
|
| 387 |
Ligand-dependent corepressor acts as a novel corepressor of thyroid hormone receptor and represses hepatic lipogenesis in mice.J Hepatol. 2012 Jan;56(1):248-54. doi: 10.1016/j.jhep.2011.07.014. Epub 2011 Aug 7.
|
| 388 |
A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression.Biochem Pharmacol. 2015 Nov 1;98(1):157-66. doi: 10.1016/j.bcp.2015.08.098. Epub 2015 Aug 20.
|
| 389 |
Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.Gastroenterology. 2014 Mar;146(3):801-11. doi: 10.1053/j.gastro.2013.11.008. Epub 2013 Nov 18.
|
| 390 |
Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma.PLoS One. 2013;8(1):e54458. doi: 10.1371/journal.pone.0054458. Epub 2013 Jan 23.
|
| 391 |
Loss of CTRP5 improves insulin action and hepatic steatosis.Am J Physiol Endocrinol Metab. 2016 Jun 1;310(11):E1036-52. doi: 10.1152/ajpendo.00010.2016. Epub 2016 May 3.
|
| 392 |
Hypolipogenic Effect of Shikimic Acid Via Inhibition of MID1IP1 and Phosphorylation of AMPK/ACC.Int J Mol Sci. 2019 Jan 29;20(3):582. doi: 10.3390/ijms20030582.
|
| 393 |
Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease. J Hepatol. 2020 Apr;72(4):627-635.
|
| 394 |
Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes.J Cell Mol Med. 2020 Jan;24(2):1399-1412. doi: 10.1111/jcmm.14818. Epub 2019 Dec 6.
|
| 395 |
Epigenetic programming at the Mogat1 locus may link neonatal overnutrition with long-term hepatic steatosis and insulin resistance.FASEB J. 2018 May 29:fj201700717RR. doi: 10.1096/fj.201700717RR. Online ahead of print.
|
| 396 |
Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease.World J Gastroenterol. 2018 Dec 28;24(48):5477-5490. doi: 10.3748/wjg.v24.i48.5477.
|
| 397 |
Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway.Gut. 2018 Dec;67(12):2169-2180. doi: 10.1136/gutjnl-2017-313778. Epub 2017 Sep 6.
|
| 398 |
Effect of ipragliflozin on liver function in Japanese type 2 diabetes mellitus patients: a subgroup analysis of the STELLA-LONG TERM study (3-month interim results).Endocr J. 2019 Jan 28;66(1):31-41. doi: 10.1507/endocrj.EJ18-0217. Epub 2018 Nov 3.
|
| 399 |
Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C.J Gastroenterol. 2015 Aug;50(8):887-93. doi: 10.1007/s00535-014-1018-z. Epub 2014 Nov 26.
|
| 400 |
Deficiency of the Mitochondrial NAD Kinase Causes Stress-Induced Hepatic Steatosis in Mice.Gastroenterology. 2018 Jan;154(1):224-237. doi: 10.1053/j.gastro.2017.09.010. Epub 2017 Sep 18.
|
| 401 |
Genome-wide analysis of hepatic lipid content in extreme obesity.Acta Diabetol. 2015 Apr;52(2):373-82. doi: 10.1007/s00592-014-0654-3. Epub 2014 Sep 23.
|
| 402 |
Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice.PLoS One. 2019 Apr 3;14(4):e0214387. doi: 10.1371/journal.pone.0214387. eCollection 2019.
|
| 403 |
Nck2 Deficiency in Mice Results in Increased Adiposity Associated With Adipocyte Hypertrophy and Enhanced Adipogenesis.Diabetes. 2016 Sep;65(9):2652-66. doi: 10.2337/db15-1559. Epub 2016 Jun 20.
|
| 404 |
Highly expressed MT-ND3 positively associated with histological severity of hepatic steatosis.APMIS. 2014 May;122(5):443-51. doi: 10.1111/apm.12166. Epub 2013 Sep 11.
|
| 405 |
Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease.Gut. 2013 Sep;62(9):1356-63. doi: 10.1136/gutjnl-2012-302962. Epub 2012 Aug 9.
|
| 406 |
Variable penetrance of metabolic phenotypes and development of high-fat diet-induced adiposity in NEIL1-deficient mice.Am J Physiol Endocrinol Metab. 2011 Apr;300(4):E724-34. doi: 10.1152/ajpendo.00387.2010. Epub 2011 Feb 1.
|
| 407 |
Nocturnin: at the crossroads of clocks and metabolism.Trends Endocrinol Metab. 2012 Jul;23(7):326-33. doi: 10.1016/j.tem.2012.03.007. Epub 2012 May 17.
|
| 408 |
Hepatic nitric oxide synthase 1 adaptor protein regulates glucose homeostasis and hepatic insulin sensitivity in obese mice depending on its PDZ binding domain.EBioMedicine. 2019 Sep;47:352-364. doi: 10.1016/j.ebiom.2019.08.033. Epub 2019 Aug 28.
|
| 409 |
Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance.Hum Mol Genet. 2011 Jan 15;20(2):312-21. doi: 10.1093/hmg/ddq466. Epub 2010 Oct 29.
|
| 410 |
Nr2e1 ablation impairs liver glucolipid metabolism and induces inflammation, high-fat diets amplify the damage.Biomed Pharmacother. 2019 Dec;120:109503. doi: 10.1016/j.biopha.2019.109503. Epub 2019 Oct 4.
|
| 411 |
Nuclear receptor cofactor receptor interacting protein 140 controls hepatic triglyceride metabolism during wasting in mice.Hepatology. 2008 Sep;48(3):782-91. doi: 10.1002/hep.22383.
|
| 412 |
Long-Acting Neurotensin Synergizes With Liraglutide to Reverse Obesity Through a Melanocortin-Dependent Pathway.Diabetes. 2019 Jun;68(6):1329-1340. doi: 10.2337/db18-1009. Epub 2019 Apr 1.
|
| 413 |
Fasting Whole-Body Energy Homeostasis and Hepatic Energy Metabolism in Nondiabetic Humans with Fatty Liver.Oxid Med Cell Longev. 2019 Apr 11;2019:9796175. doi: 10.1155/2019/9796175. eCollection 2019.
|
| 414 |
NogoB receptor in relevant carcinoma: Current achievements, challenges and aims (Review).Int J Oncol. 2018 Nov;53(5):1827-1835. doi: 10.3892/ijo.2018.4520. Epub 2018 Aug 9.
|
| 415 |
O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress.J Hepatol. 2017 Aug;67(2):310-320. doi: 10.1016/j.jhep.2017.03.017. Epub 2017 Mar 25.
|
| 416 |
Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis.J Clin Gastroenterol. 2019 Nov/Dec;53(10):750-758. doi: 10.1097/MCG.0000000000001142.
|
| 417 |
Olfactory receptor 10J5 responding to -cedrene regulates hepatic steatosis via the cAMP-PKA pathway.Sci Rep. 2017 Aug 25;7(1):9471. doi: 10.1038/s41598-017-10379-x.
|
| 418 |
New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode.PLoS One. 2019 Aug 27;14(8):e0221548. doi: 10.1371/journal.pone.0221548. eCollection 2019.
|
| 419 |
PAQR3 has modulatory roles in obesity, energy metabolism, and leptin signaling.Endocrinology. 2013 Dec;154(12):4525-35. doi: 10.1210/en.2013-1633. Epub 2013 Sep 13.
|
| 420 |
Grading fatty liver by ultrasound time-domain radiofrequency signal analysis: an in vivo study of rats.Exp Anim. 2018 May 10;67(2):249-257. doi: 10.1538/expanim.17-0124. Epub 2018 Jan 12.
|
| 421 |
Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis.Diabetes. 2008 May;57(5):1355-62. doi: 10.2337/db07-0714. Epub 2008 Mar 3.
|
| 422 |
Phosphatidylcholine transfer protein/StarD2 promotes microvesicular steatosis and liver injury in murine experimental steatohepatitis.Am J Physiol Gastrointest Liver Physiol. 2017 Jul 1;313(1):G50-G61. doi: 10.1152/ajpgi.00379.2016. Epub 2017 Apr 6.
|
| 423 |
PDIA3 Knockdown Exacerbates Free Fatty Acid-Induced Hepatocyte Steatosis and Apoptosis.PLoS One. 2015 Jul 27;10(7):e0133882. doi: 10.1371/journal.pone.0133882. eCollection 2015.
|
| 424 |
The lncRNA ENST00000608794 acts as a competing endogenous RNA to regulate PDK4 expression by sponging miR-15b-5p in dexamethasone induced steatosis.Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Oct;1864(10):1449-1457. doi: 10.1016/j.bbalip.2019.07.003. Epub 2019 Jul 19.
|
| 425 |
Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease.Am J Physiol Gastrointest Liver Physiol. 2013 Sep 1;305(5):G364-74. doi: 10.1152/ajpgi.00077.2013. Epub 2013 Jun 27.
|
| 426 |
Petite Integration Factor 1 (PIF1) helicase deficiency increases weight gain in Western diet-fed female mice without increased inflammatory markers or decreased glucose clearance.PLoS One. 2019 May 28;14(5):e0203101. doi: 10.1371/journal.pone.0203101. eCollection 2019.
|
| 427 |
PIK3R3 regulates PPAR expression to stimulate fatty acid -oxidation and decrease hepatosteatosis.Exp Mol Med. 2018 Jan 19;50(1):e431. doi: 10.1038/emm.2017.243.
|
| 428 |
MiR-17 family-mediated regulation of Pknox1 influences hepatic steatosis and insulin signaling.J Cell Mol Med. 2018 Dec;22(12):6167-6175. doi: 10.1111/jcmm.13902. Epub 2018 Oct 19.
|
| 429 |
Deficiency of CKIP-1 aggravates high-fat diet-induced fatty liver in mice.Exp Cell Res. 2017 Jun 1;355(1):40-46. doi: 10.1016/j.yexcr.2017.03.033. Epub 2017 Mar 27.
|
| 430 |
Perilipin 5 alleviates HCV NS5A-induced lipotoxic injuries in liver.Lipids Health Dis. 2019 Apr 6;18(1):87. doi: 10.1186/s12944-019-1022-7.
|
| 431 |
Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals.AIDS. 2015 Sep 24;29(15):1927-35. doi: 10.1097/QAD.0000000000000799.
|
| 432 |
Adipose tissue deficiency of hormone-sensitive lipase causes fatty liver in mice.PLoS Genet. 2017 Dec 12;13(12):e1007110. doi: 10.1371/journal.pgen.1007110. eCollection 2017 Dec.
|
| 433 |
Truncation of POC1A associated with short stature and extreme insulin resistance. J Mol Endocrinol. 2015 Oct;55(2):147-58. doi: 10.1530/JME-15-0090.
|
| 434 |
Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model.Mitochondrion. 2011 Jan;11(1):182-90. doi: 10.1016/j.mito.2010.09.007. Epub 2010 Sep 29.
|
| 435 |
The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase.Cell Metab. 2018 Jun 5;27(6):1281-1293.e7. doi: 10.1016/j.cmet.2018.04.015. Epub 2018 May 17.
|
| 436 |
Female GADD34 mice develop age-related inflammation and hepatocellular carcinoma.Geriatr Gerontol Int. 2017 Dec;17(12):2593-2601. doi: 10.1111/ggi.13080. Epub 2017 Jun 21.
|
| 437 |
Ablation of PPP1R3G reduces glycogen deposition and mitigates high-fat diet induced obesity.Mol Cell Endocrinol. 2017 Jan 5;439:133-140. doi: 10.1016/j.mce.2016.10.036. Epub 2016 Nov 2.
|
| 438 |
SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis.Obes Surg. 2010 May;20(5):633-9. doi: 10.1007/s11695-009-0052-z. Epub 2009 Dec 22.
|
| 439 |
Gain of Metabolic Benefit with Ablation of miR-149-3p from Subcutaneous Adipose Tissue in Diet-Induced Obese Mice.Mol Ther Nucleic Acids. 2019 Dec 6;18:194-203. doi: 10.1016/j.omtn.2019.07.024. Epub 2019 Aug 26.
|
| 440 |
SRY-Box Containing Gene 4 Promotes Liver Steatosis by Upregulation of SREBP-1c.Diabetes. 2018 Nov;67(11):2227-2238. doi: 10.2337/db18-0184. Epub 2018 Sep 4.
|
| 441 |
The REG proteasome regulates hepatic lipid metabolism through inhibition of autophagy.Cell Metab. 2013 Sep 3;18(3):380-91. doi: 10.1016/j.cmet.2013.08.012.
|
| 442 |
Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats.Clin Biochem. 2005 Jun;38(6):540-7. doi: 10.1016/j.clinbiochem.2005.01.013.
|
| 443 |
Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease.Life Sci. 1995;56(5):307-17. doi: 10.1016/0024-3205(94)00953-8.
|
| 444 |
Rac2 deficiency attenuates CCl(4)-induced liver injury through suppressing inflammation and oxidative stress.Biomed Pharmacother. 2017 Oct;94:140-149. doi: 10.1016/j.biopha.2017.07.074. Epub 2017 Jul 28.
|
| 445 |
Tumor suppressor RARRES1- A novel regulator of fatty acid metabolism in epithelial cells.PLoS One. 2018 Dec 17;13(12):e0208756. doi: 10.1371/journal.pone.0208756. eCollection 2018.
|
| 446 |
p107 Deficiency Increases Energy Expenditure by Inducing Brown-Fat Thermogenesis and Browning of White Adipose Tissue.Mol Nutr Food Res. 2019 Jan;63(2):e1801096. doi: 10.1002/mnfr.201801096. Epub 2018 Nov 14.
|
| 447 |
The Rbm38-p63 feedback loop is critical for tumor suppression and longevity.Oncogene. 2018 May;37(21):2863-2872. doi: 10.1038/s41388-018-0176-5. Epub 2018 Mar 9.
|
| 448 |
Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice.Gut. 2019 Aug;68(8):1504-1515. doi: 10.1136/gutjnl-2018-317232. Epub 2018 Nov 17.
|
| 449 |
Liver-specific Repin1 deficiency impairs transient hepatic steatosis in liver regeneration.Sci Rep. 2018 Nov 15;8(1):16858. doi: 10.1038/s41598-018-35325-3.
|
| 450 |
Reduced delivery of epididymal adipocyte-derived exosomal resistin is essential for melatonin ameliorating hepatic steatosis in mice.J Pineal Res. 2019 May;66(4):e12561. doi: 10.1111/jpi.12561. Epub 2019 Feb 14.
|
| 451 |
Activated TNF-/RIPK3 signaling is involved in prolonged high fat diet-stimulated hepatic inflammation and lipid accumulation: inhibition by dietary fisetin intervention.Food Funct. 2019 Mar 20;10(3):1302-1316. doi: 10.1039/c8fo01615a.
|
| 452 |
Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease.Lab Invest. 2019 Jul;99(8):1203-1216. doi: 10.1038/s41374-019-0240-y. Epub 2019 Mar 27.
|
| 453 |
Association between hepatic steatosis and hepatic expression of genes involved in innate immunity in patients with chronic hepatitis C.Cytokine. 2013 Aug;63(2):145-50. doi: 10.1016/j.cyto.2013.04.012. Epub 2013 May 11.
|
| 454 |
Deep Sequencing Reveals Novel Genetic Variants in Children with Acute Liver Failure and Tissue Evidence of Impaired Energy Metabolism.PLoS One. 2016 Aug 2;11(8):e0156738. doi: 10.1371/journal.pone.0156738. eCollection 2016.
|
| 455 |
Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway.J Biol Chem. 2018 Mar 16;293(11):3981-3988. doi: 10.1074/jbc.RA117.000885. Epub 2018 Feb 5.
|
| 456 |
S100A16, a novel lipogenesis promoting factor in livers of mice and hepatocytes in vitro.J Cell Physiol. 2019 Nov;234(11):21395-21406. doi: 10.1002/jcp.28748. Epub 2019 May 8.
|
| 457 |
Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers.PLoS One. 2018 Jan 31;13(1):e0185490. doi: 10.1371/journal.pone.0185490. eCollection 2018.
|
| 458 |
SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.Biochem Biophys Res Commun. 2018 Apr 6;498(3):416-423. doi: 10.1016/j.bbrc.2018.02.115. Epub 2018 Feb 15.
|
| 459 |
A new HIF-1/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice.Hepatology. 2016 May;63(5):1576-91. doi: 10.1002/hep.28468. Epub 2016 Mar 7.
|
| 460 |
Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism.Nat Commun. 2019 Feb 27;10(1):947. doi: 10.1038/s41467-019-08591-6.
|
| 461 |
Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease.Exp Clin Endocrinol Diabetes. 2019 Oct;127(9):598-602. doi: 10.1055/a-0811-9136. Epub 2019 Jan 9.
|
| 462 |
The inhibitory effect of ethanol on Sestrin3 in the pathogenesis of ethanol-induced liver injury.Am J Physiol Gastrointest Liver Physiol. 2014 Jul 1;307(1):G58-65. doi: 10.1152/ajpgi.00373.2013. Epub 2014 May 15.
|
| 463 |
Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor 2 suppression.Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1513-20. doi: 10.1161/ATVBAHA.113.301498. Epub 2013 May 2.
|
| 464 |
Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease.Endocr Rev. 2019 Apr 1;40(2):417-446. doi: 10.1210/er.2018-00158.
|
| 465 |
A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis.Hepatology. 2007 Jul;46(1):166-72. doi: 10.1002/hep.21688.
|
| 466 |
HIF-1 coordinates epigenetic activation of SIAH1 in hepatocytes in response to nutritional stress.Biochim Biophys Acta Gene Regul Mech. 2017 Oct;1860(10):1037-1046. doi: 10.1016/j.bbagrm.2017.08.002. Epub 2017 Aug 24.
|
| 467 |
Sirtuin 7-dependent deacetylation of DDB1 regulates the expression of nuclear receptor TR4.Biochem Biophys Res Commun. 2017 Aug 19;490(2):423-428. doi: 10.1016/j.bbrc.2017.06.057. Epub 2017 Jun 14.
|
| 468 |
Effect of miR-146 targeted HDMCP up-regulation in the pathogenesis of nonalcoholic steatohepatitis.PLoS One. 2017 Mar 27;12(3):e0174218. doi: 10.1371/journal.pone.0174218. eCollection 2017.
|
| 469 |
Secreted modular calcium-binding protein 2 promotes high fat diet (HFD)-induced hepatic steatosis through enhancing lipid deposition, fibrosis and inflammation via targeting TGF-1.Biochem Biophys Res Commun. 2019 Jan 29;509(1):48-55. doi: 10.1016/j.bbrc.2018.12.006. Epub 2018 Dec 20.
|
| 470 |
Non-proteolytic ubiquitin modification of PPAR by Smurf1 protects the liver from steatosis.PLoS Biol. 2018 Dec 19;16(12):e3000091. doi: 10.1371/journal.pbio.3000091. eCollection 2018 Dec.
|
| 471 |
Regulation of Hepatocellular Fatty Acid Uptake in Mouse Models of Fatty Liver Disease with and without Functional Leptin Signaling: Roles of NfKB and SREBP-1C and the Effects of Spexin.Semin Liver Dis. 2016 Sep;36(4):360-372. doi: 10.1055/s-0036-1597248. Epub 2016 Dec 20.
|
| 472 |
Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis.J Hepatol. 2011 Aug;55(2):445-52. doi: 10.1016/j.jhep.2010.11.022. Epub 2010 Dec 22.
|
| 473 |
Chronic exposure to Pb(2+) perturbs ChREBP transactivation and coerces hepatic dyslipidemia.FEBS Lett. 2019 Nov;593(21):3084-3097. doi: 10.1002/1873-3468.13538. Epub 2019 Jul 27.
|
| 474 |
HIF-2 upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway.Aging (Albany NY). 2019 Dec 4;11(23):10839-10860. doi: 10.18632/aging.102488. Epub 2019 Dec 4.
|
| 475 |
Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.J Hepatol. 2015 Aug;63(2):477-85. doi: 10.1016/j.jhep.2015.01.025. Epub 2015 Jan 31.
|
| 476 |
Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.Gastroenterology. 2018 Dec;155(6):1971-1984.e4. doi: 10.1053/j.gastro.2018.09.010. Epub 2018 Sep 10.
|
| 477 |
Overexpression of protein kinase STK25 in mice exacerbates ectopic lipid accumulation, mitochondrial dysfunction and insulin resistance in skeletal muscle.Diabetologia. 2017 Mar;60(3):553-567. doi: 10.1007/s00125-016-4171-5. Epub 2016 Dec 16.
|
| 478 |
SULF1/SULF2 reactivation during liver damage and tumour growth.Histochem Cell Biol. 2016 Jul;146(1):85-97. doi: 10.1007/s00418-016-1425-8. Epub 2016 Mar 25.
|
| 479 |
Suv39h2 deficiency ameliorates diet-induced steatosis in mice.Biochem Biophys Res Commun. 2017 Apr 8;485(3):658-664. doi: 10.1016/j.bbrc.2017.02.093. Epub 2017 Feb 21.
|
| 480 |
Gene mutations in hepatocellular adenomas.Histopathology. 2015 Jun;66(7):910-21. doi: 10.1111/his.12539. Epub 2014 Oct 30.
|
| 481 |
Ethanol withdrawal mitigates fatty liver by normalizing lipid catabolism.Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G509-G518. doi: 10.1152/ajpgi.00376.2018. Epub 2019 Feb 4.
|
| 482 |
Mouse trefoil factor 3 ameliorated high-fat-diet-induced hepatic steatosis via increasing peroxisome proliferator-activated receptor--mediated fatty acid oxidation.Am J Physiol Endocrinol Metab. 2019 Sep 1;317(3):E436-E445. doi: 10.1152/ajpendo.00454.2018. Epub 2019 Jun 18.
|
| 483 |
Acyl coenzyme A thioesterase Them5/Acot15 is involved in cardiolipin remodeling and fatty liver development.Mol Cell Biol. 2012 Jul;32(14):2685-97. doi: 10.1128/MCB.00312-12. Epub 2012 May 14.
|
| 484 |
Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4.Nat Med. 2017 Jun;23(6):742-752. doi: 10.1038/nm.4334. Epub 2017 May 8.
|
| 485 |
The tumor suppressor TMEM127 regulates insulin sensitivity in a tissue-specific manner.Nat Commun. 2019 Oct 17;10(1):4720. doi: 10.1038/s41467-019-12661-0.
|
| 486 |
Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation.Orphanet J Rare Dis. 2018 Jan 10;13(1):4. doi: 10.1186/s13023-017-0757-3.
|
| 487 |
Tollip Deficiency Alters Atherosclerosis and Steatosis by Disrupting Lipophagy.J Am Heart Assoc. 2017 Apr 10;6(4):e004078. doi: 10.1161/JAHA.116.004078.
|
| 488 |
Role of Tribbles Pseudokinase 1 (TRIB1) in human hepatocyte metabolism.Biochim Biophys Acta. 2016 Feb;1862(2):223-32. doi: 10.1016/j.bbadis.2015.12.003. Epub 2015 Dec 3.
|
| 489 |
TRUSS inhibition protects against high fat diet (HFD)-stimulated brain injury by alleviation of inflammatory response.Biochem Biophys Res Commun. 2019 Mar 26;511(1):41-48. doi: 10.1016/j.bbrc.2019.01.058. Epub 2019 Feb 11.
|
| 490 |
Deletion of translin (Tsn) induces robust adiposity and hepatic steatosis without impairing glucose tolerance.Int J Obes (Lond). 2020 Jan;44(1):254-266. doi: 10.1038/s41366-018-0315-7. Epub 2019 Jan 15.
|
|
|
|
|
|
|
